<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type='text/xsl' href='/w/ProjectMundo-Anon-106A/style/jats-html.xsl'?>
<!DOCTYPE response>
<article article-type="research-article" dtd-version="1.2" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    41467
   </journal-id>
   <journal-id journal-id-type="doi">
    10.1038/41467.2041-1723
   </journal-id>
   <journal-title-group>
    <journal-title>
     Nature Communications
    </journal-title>
    <abbrev-journal-title abbrev-type="publisher">
     Nat Commun
    </abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2041-1723
   </issn>
   <publisher>
    <publisher-name>
     Nature Publishing Group UK
    </publisher-name>
    <publisher-loc>
     London
    </publisher-loc>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">
    s41467-024-45446-1
   </article-id>
   <article-id pub-id-type="manuscript">
    45446
   </article-id>
   <article-id pub-id-type="doi">
    10.1038/s41467-024-45446-1
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Article
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/308/2056
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /631/208/205
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /45
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /45/23
     </subject>
    </subj-group>
    <subj-group subj-group-type="NatureArticleTypeID">
     <subject>
      article
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">
     Watoto Waliozaliwa Baada ya Uzalishaji wa Kusaidiwa Mara Nyingi Hubeba Genotype ya Mitochondria Inayohusishwa na Uzito Mdogo wa Kuzaliwa
    </article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" id="Au1">
     <name name-style="western">
      <surname>
       Mertens
      </surname>
      <given-names>
       Joke
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au2">
     <name name-style="western">
      <surname>
       Belva
      </surname>
      <given-names>
       Florence
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au3">
     <name name-style="western">
      <surname>
       van Montfoort
      </surname>
      <given-names>
       Aafke P. A.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff3">
      3
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au4">
     <name name-style="western">
      <surname>
       Regin
      </surname>
      <given-names>
       Marius
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au5">
     <name name-style="western">
      <surname>
       Zambelli
      </surname>
      <given-names>
       Filippo
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff4">
      4
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au6">
     <name name-style="western">
      <surname>
       Seneca
      </surname>
      <given-names>
       Sara
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au7">
     <name name-style="western">
      <surname>
       Couvreu de Deckersberg
      </surname>
      <given-names>
       Edouard
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au8">
     <name name-style="western">
      <surname>
       Bonduelle
      </surname>
      <given-names>
       Maryse
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au9">
     <name name-style="western">
      <surname>
       Tournaye
      </surname>
      <given-names>
       Herman
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
     <xref ref-type="aff" rid="Aff6">
      6
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au10">
     <name name-style="western">
      <surname>
       Stouffs
      </surname>
      <given-names>
       Katrien
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au11">
     <name name-style="western">
      <surname>
       Barbé
      </surname>
      <given-names>
       Kurt
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff7">
      7
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au12">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0003-3859-8522
     </contrib-id>
     <name name-style="western">
      <surname>
       Smeets
      </surname>
      <given-names>
       Hubert J. M.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff8">
      8
     </xref>
     <xref ref-type="aff" rid="Aff9">
      9
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au13">
     <name name-style="western">
      <surname>
       Van de Velde
      </surname>
      <given-names>
       Hilde
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
     <xref ref-type="aff" rid="Aff10">
      10
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au14">
     <name name-style="western">
      <surname>
       Sermon
      </surname>
      <given-names>
       Karen
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au15">
     <name name-style="western">
      <surname>
       Blockeel
      </surname>
      <given-names>
       Christophe
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
     <xref ref-type="aff" rid="Aff11">
      11
     </xref>
    </contrib>
    <contrib contrib-type="author" corresp="yes" id="Au16">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-0187-5138
     </contrib-id>
     <name name-style="western">
      <surname>
       Spits
      </surname>
      <given-names>
       Claudia
      </given-names>
     </name>
     <address>
      <email>
       claudia.spits@vub.be
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs41467024454461_cor16">
      s
     </xref>
    </contrib>
    <aff id="Aff1">
     <label>
      1
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Research Group Reproduction and Genetics, Faculty of Medicine and Pharmacy
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff2">
     <label>
      2
     </label>
     <institution-wrap>
      <institution-id institution-id-type="GRID">
       grid.411326.3
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0626 3362
      </institution-id>
      <institution content-type="org-name">
       Center for Medical Genetics, UZ Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff3">
     <label>
      3
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/02jz4aj89
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.5012.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0481 6099
      </institution-id>
      <institution content-type="org-division">
       Department of Obstetrics &amp; Gynaecology, GROW School for Oncology and Developmental Biology
      </institution>
      <institution content-type="org-name">
       Maastricht University Medical Center
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Maastricht
     </addr-line>
     <country country="NL">
      The Netherlands
     </country>
    </aff>
    <aff id="Aff4">
     <label>
      4
     </label>
     <institution-wrap>
      <institution content-type="org-division">
       Basic Research Laboratory
      </institution>
      <institution content-type="org-name">
       Eugin Group
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Barcelona
     </addr-line>
     <country country="ES">
      Spain
     </country>
    </aff>
    <aff id="Aff5">
     <label>
      5
     </label>
     <institution-wrap>
      <institution-id institution-id-type="GRID">
       grid.411326.3
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0626 3362
      </institution-id>
      <institution content-type="org-name">
       Brussels IVF, Center for Reproductive Medicine, UZ Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff6">
     <label>
      6
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Research Group Biology of the Testis, Faculty of Medicine
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff7">
     <label>
      7
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Interfaculty Center Data Processing &amp; Statistics
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff8">
     <label>
      8
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/02jz4aj89
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.5012.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0481 6099
      </institution-id>
      <institution content-type="org-division">
       Department of Toxicogenomics
      </institution>
      <institution content-type="org-name">
       Maastricht University
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Maastricht
     </addr-line>
     <country country="NL">
      The Netherlands
     </country>
    </aff>
    <aff id="Aff9">
     <label>
      9
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/02jz4aj89
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.5012.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0481 6099
      </institution-id>
      <institution content-type="org-division">
       MHeNs School Institute for Mental Health and Neuroscience, GROW Institute for Oncology and Developmental Biology
      </institution>
      <institution content-type="org-name">
       Maastricht University
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Maastricht
     </addr-line>
     <country country="NL">
      The Netherlands
     </country>
    </aff>
    <aff id="Aff10">
     <label>
      10
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Research Group Reproduction and Immunology, Faculty of Medicine and Pharmacy
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff11">
     <label>
      11
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/00mv6sv71
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.4808.4
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0657 4636
      </institution-id>
      <institution content-type="org-division">
       Department of Obstetrics and Gynaecology, School of Medicine
      </institution>
      <institution content-type="org-name">
       University of Zagreb
      </institution>
     </institution-wrap>
     <addr-line content-type="street">
      Šalata 3
     </addr-line>
     <addr-line content-type="postcode">
      10000
     </addr-line>
     <addr-line content-type="city">
      Zagreb
     </addr-line>
     <country country="HR">
      Croatia
     </country>
    </aff>
   </contrib-group>
   <author-notes>
    <corresp id="IDs41467024454461_cor16">
     <label>
      s
     </label>
     <email>
      claudia.spits@vub.be
     </email>
    </corresp>
   </author-notes>
   <pub-date date-type="pub" publication-format="electronic">
    <day>
     9
    </day>
    <month>
     2
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <pub-date date-type="collection" publication-format="electronic">
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <volume>
    15
   </volume>
   <issue seq="1232">
    1
   </issue>
   <elocation-id>
    1232
   </elocation-id>
   <history>
    <date date-type="registration">
     <day>
      24
     </day>
     <month>
      1
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="received">
     <day>
      10
     </day>
     <month>
      12
     </month>
     <year>
      2022
     </year>
    </date>
    <date date-type="accepted">
     <day>
      23
     </day>
     <month>
      1
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="online">
     <day>
      9
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
   </history>
   <permissions>
    <copyright-statement content-type="compact">
     © The Author(s) 2024
    </copyright-statement>
    <copyright-year>
     2024
    </copyright-year>
    <copyright-holder>
     The Author(s)
    </copyright-holder>
    <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
     <license-p>
      <bold>
       Open Access
      </bold>
      This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit
      <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
       http://creativecommons.org/licenses/by/4.0/
      </ext-link>
      .
     </license-p>
    </license>
   </permissions>
   <abstract id="Abs1" xml:lang="en">
    <title>
     Muhtasari
    </title>
    <p id="Par1">
     Watoto waliozaliwa kupitia teknolojia za uzazi wa kusaidiwa (ART) wana hatari kubwa ya kuwa na uzito mdogo wa kuzaliwa, lakini sababu ya msingi bado haijafahamika. Utafiti wetu unachunguza tofauti za DNA ya mitochondria (mtDNA) kama wachangiaji wa tofauti za uzito wa kuzaliwa kwa kuathiri kazi ya mitochondria wakati wa maendeleo ya kabla ya kuzaliwa. Tulifuatilia kwa kina mtDNA ya watu 451 wa ART na waliozaliwa kwa njia ya kawaida (SC), jozi 157 za mama na mtoto na oocytes 113 za kibinafsi kutoka kwa mizunguko ya kawaida ya hedhi au baada ya kuchochea ovari (OS) na kugundua kuwa watu wa ART walibeba genotype tofauti ya mtDNA kuliko watu wa SC, wakiwa na tofauti zaidi za de novo zisizo za kinasaba. Tofauti hizi, pamoja na tofauti za rRNA, zinahusiana na asilimia za chini za uzito wa kuzaliwa, bila kujali njia ya mimba. Uwepo wao wa juu katika watu wa ART unatokana na mabadiliko ya de novo yanayohusishwa na kuzeeka kwa mama na ukubwa wa kundi la oocyte lililosababishwa na OS. Utafiti wa baadaye utaanzisha athari za muda mrefu za kiafya za mabadiliko haya na jinsi matokeo haya yatakavyoathiri mazoezi ya kliniki na ushauri wa wagonjwa katika siku zijazo.
    </p>
   </abstract>
   <abstract abstract-type="ShortSummary" id="Abs2" xml:lang="en">
    <p id="Par2">
     Assisted reproduction increases low birthweight risk in children. This study finds a mitochondrial DNA genotype that is more common in ART children, associates to birthweight and that is linked to maternal ageing and to ovarian stimulation.
    </p>
   </abstract>
   <kwd-group kwd-group-type="hierarchical" vocab="FoR" vocab-identifier="ANZSRC 2008">
    <kwd content-type="term" vocab-term-identifier="11">
     Medical and Health Sciences
    </kwd>
    <nested-kwd>
     <kwd content-type="term" vocab-term-identifier="1114">
      Paediatrics and Reproductive Medicine
     </kwd>
    </nested-kwd>
   </kwd-group>
   <funding-group>
    <award-group>
     <funding-source>
      <institution-wrap>
       <institution>
        Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders)
       </institution>
       <institution-id institution-id-type="doi" vocab="open-funder-registry">
        https://doi.org/10.13039/501100003130
       </institution-id>
      </institution-wrap>
     </funding-source>
    </award-group>
   </funding-group>
   <custom-meta-group>
    <custom-meta>
     <meta-name>
      publisher-imprint-name
     </meta-name>
     <meta-value>
      Nature Portfolio
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-issue-count
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-article-count
     </meta-name>
     <meta-value>
      1232
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-pricelist-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-holder
     </meta-name>
     <meta-value>
      Springer Nature Limited
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-contains-esm
     </meta-name>
     <meta-value>
      Yes
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-month
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-day
     </meta-name>
     <meta-value>
      24
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-product
     </meta-name>
     <meta-value>
      NonStandardArchiveJournal
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-grants-type
     </meta-name>
     <meta-value>
      OpenChoice
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      metadata-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      abstract-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodypdf-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodyhtml-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bibliography-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      esm-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      online-first
     </meta-name>
     <meta-value>
      false
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-file-reference
     </meta-name>
     <meta-value>
      BodyRef/PDF/41467_2024_Article_45446.pdf
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-type
     </meta-name>
     <meta-value>
      Typeset
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      target-type
     </meta-name>
     <meta-value>
      OnlinePDF
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-type
     </meta-name>
     <meta-value>
      OriginalPaper
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-primary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-collection
     </meta-name>
     <meta-value>
      Science (multidisciplinary)
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      open-access
     </meta-name>
     <meta-value>
      true
     </meta-value>
    </custom-meta>
   </custom-meta-group>
  </article-meta>
 </front>
 <body>
  <sec id="Sec1" sec-type="introduction">
   <title>
    Utangulizi
   </title>
   <p id="Par3">
    Kuzaliwa kwa Louise Brown mwaka 1978 kulianzisha mapinduzi katika tiba ya uzazi ambayo imewezesha uzazi kwa wanandoa waliokuwa wakichukuliwa kuwa hawana uwezo wa kuzaa. Tangu wakati huo, teknolojia za uzazi zilizosaidiwa (ART) zimepitia maendeleo makubwa na matumizi yake yameongezeka kwa kasi, na zaidi ya watoto milioni 8 wamezaliwa duniani kote. Katika miongo iliyopita, karibu hatua zote za mchakato zimeboreshwa kwa kuendelea. Hata hivyo, wasiwasi kuhusu usalama wa taratibu hizi kuhusiana na afya ya watoto wanaozaliwa baada ya ART umekuwepo daima, na tafiti za kimfumo za makundi makubwa ya watoto kwa miaka mingi zimeonyesha kuwa watu hawa wana matokeo mabaya ya kiafya ikilinganishwa na wale waliozaliwa baada ya mimba ya kawaida (SC). Sasa kuna ushahidi mwingi kwamba watoto wa ART wako katika hatari kubwa ya kuzaliwa na kasoro za kuzaliwa na kuwa wadogo kwa umri wa ujauzito, huku watoto wa ART wakiwa na hatari ya mara 2 hadi 3 ya matokeo mabaya ya uzazi
    <sup>
     <xref ref-type="bibr" rid="CR1">
      1
     </xref>
     ,
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     ,
     <xref ref-type="bibr" rid="CR3">
      3
     </xref>
     ,
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
    </sup>
    . Kinyume chake, watoto kutoka uhamisho wa kiinitete kilichogandishwa wana hatari kubwa ya kuzaliwa wakiwa wakubwa kwa umri wa ujauzito, jambo ambalo linahusishwa na ugumu wakati wa kujifungua, saratani za utotoni na matatizo ya moyo na kimetaboliki
    <sup>
     <xref ref-type="bibr" rid="CR5">
      5
     </xref>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
     ,
     <xref ref-type="bibr" rid="CR7">
      7
     </xref>
    </sup>
    . Tafiti za ufuatiliaji wa muda mrefu zinaonyesha ushahidi unaoongezeka kwamba watoto hawa wako katika hatari ya kuwa na wasifu wa homoni na kimetaboliki ya moyo isiyo ya kawaida baadaye maishani
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
     ,
     <xref ref-type="bibr" rid="CR9">
      9
     </xref>
     ,
     <xref ref-type="bibr" rid="CR10">
      10
     </xref>
     ,
     <xref ref-type="bibr" rid="CR11">
      11
     </xref>
     ,
     <xref ref-type="bibr" rid="CR12">
      12
     </xref>
     ,
     <xref ref-type="bibr" rid="CR13">
      13
     </xref>
     ,
     <xref ref-type="bibr" rid="CR14">
      14
     </xref>
    </sup>
    .
   </p>
   <p id="Par4">
    Kwa miaka mingi, utafiti mkubwa umejitolea kutambua sababu na msingi wa molekuli wa athari hizi mbaya kwa watoto wa ART, kwa kuzingatia maarifa kwamba hali duni za maendeleo ya awali zina athari kubwa kwa afya ya baadaye ya mtu binafsi
    <sup>
     <xref ref-type="bibr" rid="CR15">
      15
     </xref>
    </sup>
    . Mambo matatu yamekuwa yakisomwa hasa kuhusiana na afya ya watoto wa ART, ambayo ni utasa wa mama, kuchochea ovari (OS) na mifumo ya utamaduni wa kiinitete. Hata hivyo, matokeo yanayokinzana ya tafiti tofauti hufanya iwe vigumu kubaini jukumu halisi la kila sababu katika tabia ya watoto. Kwanza, matokeo mabaya ya kiafya yanayoonekana kwa watoto wa ART yamehusishwa na utasa wa mama zao
    <sup>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="CR16">
      16
     </xref>
     ,
     <xref ref-type="bibr" rid="CR17">
      17
     </xref>
     ,
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
    </sup>
    . Sambamba na hili, watoto wa SC waliozaliwa na mama wasio na uwezo wa kuzaa pia wana hatari kubwa ya matokeo mabaya ya uzazi, ikionyesha jukumu kubwa la asili ya mama (kijenetiki). Pili, utaratibu wa OS, unaotumika katika ART kuongeza kundi la oocytes zinazopatikana katika mzunguko mmoja wa hedhi umeonyeshwa kuathiri uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
     ,
     <xref ref-type="bibr" rid="CR19">
      19
     </xref>
     ,
     <xref ref-type="bibr" rid="CR20">
      20
     </xref>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
    </sup>
    . Imependekezwa kuwa mazingira ya uterasi ya mama chini ya ushawishi wa OS hufanya kama mchangiaji huru kwa hatari ya uzito wa chini wa kuzaliwa kwa watoto wanaozaliwa kufuatia uhamisho wa kiinitete kipya, kinyume na uhamisho wa kiinitete kilichogandishwa
    <sup>
     <xref ref-type="bibr" rid="CR21">
      21
     </xref>
    </sup>
    . Hata hivyo, tafiti za kulinganisha watoto waliozaliwa baada ya OS na watoto wa SC kutoka kwa wazazi wasio na uwezo wa kuzaa hazikupata tofauti kubwa
    <sup>
     <xref ref-type="bibr" rid="CR22">
      22
     </xref>
     ,
     <xref ref-type="bibr" rid="CR23">
      23
     </xref>
    </sup>
    . Tatu, uendeshaji wa kiinitete kwa njia ya vitro, ikiwa ni pamoja na kugandisha na kuyeyusha, na hasa matumizi ya vyombo vya utamaduni tofauti umeonyeshwa kuwa na athari kubwa kwa uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR24">
      24
     </xref>
     ,
     <xref ref-type="bibr" rid="CR25">
      25
     </xref>
     ,
     <xref ref-type="bibr" rid="CR26">
      26
     </xref>
    </sup>
    . Kwa sababu vituo vya ART duniani kote vinatumia vyombo tofauti, na hivi vimekuwa vikibadilika kwa muda, kuanzisha athari halisi na sababu zinazohusika katika vyombo kwa afya ya mtoto wa ART inabaki kuwa changamoto
    <sup>
     <xref ref-type="bibr" rid="CR27">
      27
     </xref>
     ,
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
    </sup>
    .
   </p>
   <p id="Par5">
    Kutoka kwa mtazamo wa molekuli, idadi kubwa ya tafiti zimejikita katika kutafuta mabadiliko ya epijenetiki yanayosababishwa na ART, katika watu binafsi na katika sampuli za plasenta. Ingawa idadi kubwa ya tafiti za wanyama zimeonyesha uhusiano kati ya mabadiliko ya epijenetiki na vipengele tofauti vya ART, tafiti kwa binadamu hazikutoa matokeo ya uhakika
    <sup>
     <xref ref-type="bibr" rid="CR29">
      29
     </xref>
    </sup>
    . Wakati tafiti zingine zimepata tofauti katika mandhari ya epijenetiki ya watoto wa ART na SC, hizi kwa kawaida zilikuwa ndani ya kiwango cha kawaida cha tofauti. Watafiti wengi wengine hawajatambua mabadiliko ya methylation yanayolingana katika jenomu ya watoto wa ART, na kusababisha matokeo ambayo ni vigumu kuoanisha kimataifa na bila uhusiano na matokeo ya afya ya watoto wa ART. Hatimaye, utafiti wa hivi karibuni ulionyesha kuwa mbolea ya vitro haiongezi matukio ya kasoro za kromosomu katika mistari ya fetasi na plasenta za binadamu, na haikupata uhusiano kati ya uwepo wa kasoro hizi na uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR30">
      30
     </xref>
     ,
     <xref ref-type="bibr" rid="CR31">
      31
     </xref>
     <xref ref-type="bibr" rid="CR32">
      32
     </xref>
     ,
     <xref ref-type="bibr" rid="CR33">
      33
     </xref>
     ,
     <xref ref-type="bibr" rid="CR34">
      34
     </xref>
     ,
     <xref ref-type="bibr" rid="CR35">
      35
     </xref>
     ,
     <xref ref-type="bibr" rid="CR36">
      36
     </xref>
     <xref ref-type="bibr" rid="CR37">
      37
     </xref>
    </sup>
    .
   </p>
   <p id="Par6">
    Katika utafiti huu, tulidhani kwamba tofauti za uzito wa kuzaliwa kati ya watoto wa ART na SC zinasababishwa na tofauti za DNA ya mitochondria (mtDNA). Katika idadi ya watu kwa ujumla, uzito wa chini wa kuzaliwa unahusishwa na matatizo ya kimetaboliki, ambayo katika utu uzima yamehusishwa na kutofanya kazi vizuri kwa mitochondria
    <sup>
     <xref ref-type="bibr" rid="CR38">
      38
     </xref>
     <xref ref-type="bibr" rid="CR39">
      39
     </xref>
    </sup>
    . Zaidi ya hayo, kasoro za mtDNA zilizorithiwa zinaweza kusababisha unene kupita kiasi na upinzani wa insulini, uzito wa chini wa kuzaliwa ni wa kawaida kwa watu waliozaliwa na ugonjwa wa mtDNA na tofauti za mtDNA zisizohusiana na ugonjwa zimepatikana awali kuhusishwa na muundo wa mwili na uzito
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
     <xref ref-type="bibr" rid="CR41">
      41
     </xref>
     ,
     <xref ref-type="bibr" rid="CR42">
      42
     </xref>
     <xref ref-type="bibr" rid="CR43">
      43
     </xref>
     ,
     <xref ref-type="bibr" rid="CR44">
      44
     </xref>
     ,
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR46">
      46
     </xref>
     ,
     <xref ref-type="bibr" rid="CR47">
      47
     </xref>
     ,
     <xref ref-type="bibr" rid="CR48">
      48
     </xref>
     ,
     <xref ref-type="bibr" rid="CR49">
      49
     </xref>
     ,
     <xref ref-type="bibr" rid="CR50">
      50
     </xref>
    </sup>
    . Kama ilivyotajwa hapo juu, utasa wa wanawake na OS unahusishwa sana na hatari ya uzito wa chini wa kuzaliwa kwa watoto wa ART, na zote mbili zinaweza kuhusishwa na kazi ya mitochondria kwani fosforasi ya oksidi ina jukumu muhimu wakati wa gametogenesis, maendeleo ya kiinitete na pia katika utasa wa wanawake
    <sup>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="CR51">
      51
     </xref>
     <xref ref-type="bibr" rid="CR52">
      52
     </xref>
     ,
     <xref ref-type="bibr" rid="CR53">
      53
     </xref>
     ,
     <xref ref-type="bibr" rid="CR54">
      54
     </xref>
     ,
     <xref ref-type="bibr" rid="CR55">
      55
     </xref>
     ,
     <xref ref-type="bibr" rid="CR56">
      56
     </xref>
     ,
     <xref ref-type="bibr" rid="CR57">
      57
     </xref>
     ,
     <xref ref-type="bibr" rid="CR58">
      58
     </xref>
    </sup>
    . Tulidhani kwamba wanawake wasio na uwezo wa kuzaa mara nyingi hubeba tofauti za mtDNA ambazo huathiri vibaya kazi ya mitochondria na kuchangia utasa wao. Zaidi ya hayo, kazi katika mifano ya wanyama inapendekeza kwamba OS huongeza marudio ya kufutwa kwa mtDNA katika oocytes na huathiri kazi ya mitochondria
    <sup>
     <xref ref-type="bibr" rid="CR59">
      59
     </xref>
     ,
     <xref ref-type="bibr" rid="CR60">
      60
     </xref>
     <xref ref-type="bibr" rid="CR61">
      61
     </xref>
    </sup>
    . Kwa hiyo, tulidhani kwamba usambazaji wa mama wa genotypes za mtDNA, ambazo zinaweza kuhusiana na utasa, na mutajeni ya de novo wakati wa OS inaweza kusababisha matokeo mabaya ya uzazi kwa watoto wanaobeba genotypes hizi za mtDNA.
   </p>
   <p id="Par7">
    Ili kujaribu kama genotypes za mtDNA za watoto wa ART na SC zinatofautiana, kama tofauti hizi zinahusishwa na asilimia ya uzito wa kuzaliwa na kubaini asili ya tofauti hizi zinazowezekana, tulisoma jenomu ya mitochondria ya watoto 270 wa ART na 181 wa SC, jozi 157 za mama na mtoto wa ART na SC na oocytes 113 zilizotolewa katika mizunguko ya hedhi ya asili na baada ya OS kutoka kwa wafadhili sawa kwa kutumia upimaji wa sambamba wa wingi.
   </p>
  </sec>
  <sec id="Sec2" sec-type="results">
   <title>
    Matokeo
   </title>
   <sec id="Sec3">
    <title>
     Watu waliozaliwa baada ya ART wanaonyesha aina tofauti ya jenotipu ya mabadiliko ya DNA ya mitochondrial kuliko wenzao waliozaliwa kwa njia ya kawaida
    </title>
    <p id="Par8">
     Kwanza, tulipanga mlolongo wa jeni kamili la mitochondrial la watoto 270 wa ART na 181 wa SC (maelezo kuhusu washiriki na chanzo cha DNA yanaweza kupatikana katika Jedwali
     <xref ref-type="table" rid="Tab1">
      1
     </xref>
     ). Wakati wa usindikaji wa data, tuliondoa 1037 bp ambazo zilijumuisha maeneo yaliyokuwa na uwezekano wa makosa ya PCR na upangaji mlolongo (Fig.
     <xref ref-type="fig" rid="Fig1">
      1a
     </xref>
     ).
     <fig id="Fig1" position="float">
      <label>
       Fig. 1
      </label>
      <caption xml:lang="en">
       <title>
        Watu wa ART hubeba genotipu tofauti ya DNA ya mitochondrial kuliko wenzao waliozaliwa kwa njia ya kawaida.
       </title>
       <p>
        <bold>
         a
        </bold>
        Muhtasari wa mpangilio wa mtDNA unaoonyesha kwa rangi ya machungwa maeneo ambayo yaliondolewa kwenye uchambuzi. Imetoholewa kwa ruhusa kutoka ref.
        <sup>
         <xref ref-type="bibr" rid="CR112">
          112
         </xref>
        </sup>
        , Haki miliki © 2009 International Union of Biochemistry and Molecular Biology, Inc.
        <bold>
         b
        </bold>
        ,
        <bold>
         c
        </bold>
        Jaribio sahihi la Fisher linaonyesha hakuna tofauti kubwa katika usambazaji wa haplogrupu tofauti (
        <bold>
         b
        </bold>
        ) na subhaplogrupu (
        <bold>
         c
        </bold>
        ) kati ya watu wa ART na SC.
        <bold>
         d
        </bold>
        Jaribio sahihi la Fisher linaonyesha hakuna tofauti kubwa katika usambazaji wa watu wa ART na SC wenye tofauti za homoplasmic zilizoko katika makundi tofauti. Asilimia hazijafikia 100% kwa sababu mtu mmoja anaweza kuwa na zaidi ya tofauti moja.
        <bold>
         e
        </bold>
        Muhtasari wa tofauti zote za heteroplasmic zilizotambuliwa. Nne kati ya jeni za tRNA hazikuonyeshwa katika seti yetu ya data. Kila kiputo kinawakilisha tofauti moja na ukubwa wa kiputo ni sawia na mzigo wa heteroplasmic wa tofauti hiyo.
        <bold>
         f
        </bold>
        ,
        <bold>
         g
        </bold>
        Jumla ya mizigo ya heteroplasmic iliyotambuliwa kwa kila sampuli, iliyoorodheshwa kulingana na tishu za asili (
        <bold>
         f
        </bold>
        ) na umri wakati wa sampuli (
        <bold>
         g
        </bold>
        ). Jaribio la Kruskal–Wallis linaonyesha hakuna tofauti kubwa. Damu
        <italic>
         n
        </italic>
        = 168, Placenta
        <italic>
         n
        </italic>
        = 117, Mate na Swabu ya Mdomo
        <italic>
         n
        </italic>
        = 166, wakati wa kuzaliwa
        <italic>
         n
        </italic>
        = 163, miaka 9
        <italic>
         n
        </italic>
        = 106, miaka 18
        <italic>
         n
        </italic>
        = 182.
        <bold>
         h
        </bold>
        Idadi ya tofauti zilizotambuliwa kwa kila mtu. Jaribio la Chi-square linaonyesha hakuna tofauti kubwa (tofaouti zisizo za kinasaba,
        <italic>
         p
        </italic>
        = 0.067).
        <bold>
         i
        </bold>
        Kiwango cha mabadiliko kwa kila eneo au jeni la kutengeneza protini, kwa kila mtu katika ART na SC.
        <bold>
         j
        </bold>
        Jumla ya mizigo ya tofauti za heteroplasmic zilizopatikana kwa kila mtu na kwa kila eneo. Jaribio la Mann–Whitney U linaonyesha hakuna tofauti kubwa.
        <italic>
         n
        </italic>
        = 270 ART,
        <italic>
         n
        </italic>
        = 181 SC.
        <bold>
         k
        </bold>
        Matriksi ya vipengele vilivyotengenezwa na uchambuzi wa vipengele.
        <bold>
         l
        </bold>
        Hypercube inayoonyesha ushirikiano kati ya makundi tofauti ya tofauti za heteroplasmic. Rangi zinaonyesha makundi yanayoshirikiana katika kipengele kimoja.
        <bold>
         m
        </bold>
        Watu wa ART mara nyingi hubeba alama za juu kwa kipengele cha 2 (*Jaribio la Mann–Whitney U,
        <italic>
         p
        </italic>
        = 0.021).
        <italic>
         n
        </italic>
        = 270 ART,
        <italic>
         n
        </italic>
        = 181 SC. Mipira ya usawa katika paneli (
        <bold>
         f
        </bold>
        ), (
        <bold>
         g
        </bold>
        ), (
        <bold>
         j
        </bold>
        ) na (
        <bold>
         m
        </bold>
        ) inawakilisha wastani wa thamani katika mchoro wa kutawanya, kila nukta inawakilisha sampuli. Data ya chanzo imetolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig1_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
     <table-wrap id="Tab1">
      <label>
       Jedwali 1
      </label>
      <caption xml:lang="en">
       <p>
        Sifa za watu wa ART na SC waliowekwa katika utafiti huu
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th rowspan="2"/>
         <th>
          <p>
           ART
          </p>
         </th>
         <th>
          <p>
           SC
          </p>
         </th>
         <th rowspan="2">
          <p>
           <italic>
            P
           </italic>
           -thamani
          </p>
         </th>
        </tr>
        <tr>
         <th>
          <p>
           (
           <italic>
            N
           </italic>
           = 270)
          </p>
         </th>
         <th>
          <p>
           (
           <italic>
            N
           </italic>
           = 181)
          </p>
         </th>
        </tr>
        <tr>
         <th/>
         <th colspan="2">
          <p>
           % (
           <italic>
            N
           </italic>
           )
          </p>
         </th>
         <th/>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            Chanzo cha nyenzo
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Damu
           <sup>
            1
           </sup>
          </p>
         </td>
         <td>
          <p>
           38.1% (103)
          </p>
         </td>
         <td>
          <p>
           35.9% (65)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Watoto wachanga
          </p>
         </td>
         <td>
          <p>
           17.0% (46)
          </p>
         </td>
         <td>
          <p>
           0.0% (0)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vijana watu wazima
          </p>
         </td>
         <td>
          <p>
           21.1% (57)
          </p>
         </td>
         <td>
          <p>
           35.9% (65)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Placenta
           <sup>
            2
           </sup>
          </p>
         </td>
         <td>
          <p>
           24.4% (66)
          </p>
         </td>
         <td>
          <p>
           28.2% (51)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Seli za mdomo
           <sup>
            3
           </sup>
           &amp; Mate
           <sup>
            2
           </sup>
          </p>
         </td>
         <td>
          <p>
           37.4% (101)
          </p>
         </td>
         <td>
          <p>
           35.9% (65)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Watoto
          </p>
         </td>
         <td>
          <p>
           37.4% (101)
          </p>
         </td>
         <td>
          <p>
           2.8% (5)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vijana watu wazima
          </p>
         </td>
         <td>
          <p>
           0.0% (0)
          </p>
         </td>
         <td>
          <p>
           33.1% (60)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Jozi za mama na mtoto
          </p>
         </td>
         <td>
          <p>
           67
          </p>
         </td>
         <td>
          <p>
           90
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            Vigezo vya kliniki
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa wastani wa mama
           <sup>
            4
           </sup>
           ± SD*
          </p>
         </td>
         <td>
          <p>
           32.5 ± 3.7 (211)
          </p>
         </td>
         <td>
          <p>
           30.1 ± 4.4 (173)
          </p>
         </td>
         <td>
          <p>
           &lt;0.0001
           <sup>
            a
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           BMI ya mama &gt; 25*
          </p>
         </td>
         <td>
          <p>
           40.2% (86/214)
          </p>
         </td>
         <td>
          <p>
           25.6% (42/164)
          </p>
         </td>
         <td>
          <p>
           0.0031
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Uzito wa kuzaliwa*
          </p>
         </td>
         <td>
          <p>
           (224)
          </p>
         </td>
         <td>
          <p>
           (164)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Wastani (gramu) ± SD
          </p>
         </td>
         <td>
          <p>
           3377.9 ± 536.0
          </p>
         </td>
         <td>
          <p>
           3394.3 ± 500.7
          </p>
         </td>
         <td>
          <p>
           0.7596
           <sup>
            a
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           &lt;10th asilimia
          </p>
         </td>
         <td>
          <p>
           7.0% (19)
          </p>
         </td>
         <td>
          <p>
           5.0% (9)
          </p>
         </td>
         <td>
          <p>
           0.2407
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           &lt;25th asilimia
          </p>
         </td>
         <td>
          <p>
           15.2% (41)
          </p>
         </td>
         <td>
          <p>
           14.4% (26)
          </p>
         </td>
         <td>
          <p>
           0.4992
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuzaliwa kabla ya wakati (&lt;wiki 37)*
          </p>
         </td>
         <td>
          <p>
           5.8% (13/224)
          </p>
         </td>
         <td>
          <p>
           6.1% (10/164)
          </p>
         </td>
         <td>
          <p>
           1.0000
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Jinsia*
          </p>
         </td>
         <td>
          <p>
           (224)
          </p>
         </td>
         <td>
          <p>
           (181)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           (Mwanaume–Mwanamke)
          </p>
         </td>
         <td>
          <p>
           41.5% (112) –41.5% (112)
          </p>
         </td>
         <td>
          <p>
           44.8% (81) –55.2% (100)
          </p>
         </td>
         <td>
          <p>
           0.3176
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Utaratibu wa utamaduni
          </p>
         </td>
         <td>
          <p>
           224
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vitrolife® G3
          </p>
         </td>
         <td>
          <p>
           19.3% (52)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vitrolife® G5
          </p>
         </td>
         <td>
          <p>
           24.4% (66)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Cook®
          </p>
         </td>
         <td>
          <p>
           18.1% (49)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           UZB
          </p>
         </td>
         <td>
          <p>
           21.1% (57)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Haijulikani
          </p>
         </td>
         <td>
          <p>
           17.0% (46)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Shinikizo la damu wakati wa ujauzito*
          </p>
         </td>
         <td>
          <p>
           4.1% (8/193)
          </p>
         </td>
         <td>
          <p>
           1.9% (3/159)
          </p>
         </td>
         <td>
          <p>
           0.3571
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kisukari cha ujauzito*
          </p>
         </td>
         <td>
          <p>
           1.0% (2/193)
          </p>
         </td>
         <td>
          <p>
           1.3% (2/158)
          </p>
         </td>
         <td>
          <p>
           1.0000
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Uzazi wa kwanza*
          </p>
         </td>
         <td>
          <p>
           75.2% (167/222)
          </p>
         </td>
         <td>
          <p>
           47.2% (68/144)
          </p>
         </td>
         <td>
          <p>
           &lt;0.0001
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuvuta sigara wakati wa ujauzito*
          </p>
         </td>
         <td>
          <p>
           5.5% (12/220)
          </p>
         </td>
         <td>
          <p>
           7.7% (13/169)
          </p>
         </td>
         <td>
          <p>
           0.4086
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        Wachangiaji walikusanywa katika vituo tofauti:
        <sup>
         1
        </sup>
        UZ Brussel, Ubelgiji,
        <sup>
         2
        </sup>
        Kituo cha Matibabu cha Chuo Kikuu cha Maastricht, Uholanzi na
        <sup>
         3
        </sup>
        Fakulti ya Tiba na Dawa, Vrije Universiteit Brussel, Ubelgiji.
        <sup>
         4
        </sup>
        Umri kwa miaka.
       </p>
       <p>
        <italic>
         ART
        </italic>
        teknolojia za uzazi zilizosaidiwa,
        <italic>
         SC
        </italic>
        zilizotungwa kwa hiari,
        <italic>
         SD
        </italic>
        tofauti ya kawaida,
        <italic>
         BMI
        </italic>
        kipimo cha mwili.
       </p>
       <p>
        *Ni sehemu tu ya sampuli zilizotolewa na data za kliniki kama vile umri wa mama, BMI ya mama (kipimo cha mwili), uzito wa kuzaliwa (umekatizwa katika asilimia), umri wa ujauzito, jinsia, utaratibu wa utamaduni, matatizo wakati wa ujauzito na uzazi. UZB ilikuwa ni utaratibu wa ndani uliofanywa katika UZ Brussel. Wote ni watoto wa pekee kutoka kwa uhamisho wa kiinitete safi. Baadhi ya sifa hazikuweza kutumika (NA) kwa baadhi ya sampuli.
        <italic>
         N
        </italic>
        inaonyesha idadi ya sampuli ambazo data hii ilipatikana. Vipimo vya takwimu vya pande mbili vilifanywa kwa kutumia mtihani wa mwanafunzi t (
        <sup>
         a
        </sup>
        ) au mtihani halisi wa Fisher (
        <sup>
         b
        </sup>
        ).
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
    <p id="Par9">
     Kwanza, data ilidhibitiwa kwa tofauti katika usambazaji wa haplogroup. Hakuna tofauti kubwa zilizopatikana katika usambazaji wa haplogroup na subhaplogroup kati ya watu wa ART na SC (Fig.
     <xref ref-type="fig" rid="Fig1">
      1b
     </xref>
     ,
     <xref ref-type="fig" rid="Fig1">
      c
     </xref>
     , na Jedwali la Nyongeza
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ). Mbali na tofauti za haplogroup, watu wengi walibeba tofauti za homoplasmic za ziada, ambazo ziliorodheshwa kulingana na eneo lao katika jeni la mitochondrial na athari zao kwenye mlolongo wa amino asidi: eneo lenye mabadiliko mengi (HV), lisilo na msimbo, asili ya uzazi kwenye uzi mzito (OHR), mlolongo unaohusishwa na kukomesha (TAS), rRNA, tRNA, tofauti za msimbo wa protini za synonymous (Syn) na zisizo za synonymous (Non-syn). Uwiano wa watu wanaobeba tofauti za homoplasmic ulikuwa sawa katika makundi yote mawili, pamoja na eneo la tofauti na uwezekano wao wa kusababisha magonjwa (Fig.
     <xref ref-type="fig" rid="Fig1">
      1d
     </xref>
     na Jedwali la Nyongeza
     <xref ref-type="supplementary-material" rid="MOESM1">
      3
     </xref>
     ). Mtu mmoja wa SC alibeba tofauti ya tRNA inayothibitishwa kuwa na magonjwa katika kiwango cha homoplasmic (mt.14674 T &gt; C, inayohusishwa na Upungufu wa Mnyororo wa Kupumua wa Watoto Unaoweza Kubadilika)
     <sup>
      <xref ref-type="bibr" rid="CR62">
       62
      </xref>
     </sup>
     .
    </p>
    <p id="Par10">
     Kwa jumla, tofauti 430 za heteroplasmic zilitambuliwa, 66.0% ya ambazo zilikuwa za kipekee kwa mtu mmoja (muhtasari unaonyeshwa katika Fig.
     <xref ref-type="fig" rid="Fig1">
      1e
     </xref>
     ). Kwa kuwa tofauti za heteroplasmic zinaweza kutofautiana katika tishu tofauti na kuongezeka na umri, kwanza tulidhibiti seti ya data kwa matumizi ya tishu tofauti kama chanzo cha DNA na umri tofauti wakati wa sampuli. Hatukupata tofauti kubwa katika jumla ya mizigo tofauti ya heteroplasmic kwa kila mtu kuhusiana na chanzo cha sampuli ya DNA au umri wakati wa sampuli (Fig.
     <xref ref-type="fig" rid="Fig1">
      1f
     </xref>
     ,
     <xref ref-type="fig" rid="Fig1">
      g
     </xref>
     ). Kisha, tuliorodhesha tofauti za heteroplasmic kwa eneo, kama ilivyofanywa kwa tofauti za homoplasmic. 60.4% ya watu wa ART na 61.9% ya watu wa SC walibeba hadi tofauti 5 za heteroplasmic kwa kila mtu, bila tofauti kubwa katika usambazaji wao (Fig.
     <xref ref-type="fig" rid="Fig1">
      1h
     </xref>
     , Jedwali la Nyongeza
     <xref ref-type="supplementary-material" rid="MOESM1">
      4
     </xref>
     ). Pia hakukuwa na tofauti za kitakwimu katika usambazaji wa tofauti katika maeneo yasiyo na msimbo, tRNA, rRNA na tofauti za synonymous na zisizo za synonymous, ingawa watu wa ART mara nyingi zaidi walibeba tofauti za msimbo wa protini zisizo za synonymous (Fig.
     <xref ref-type="fig" rid="Fig1">
      1h
     </xref>
     , Jedwali la Nyongeza
     <xref ref-type="supplementary-material" rid="MOESM1">
      4
     </xref>
     )
     <sup>
      <xref ref-type="bibr" rid="CR63">
       63
      </xref>
      ,
      <xref ref-type="bibr" rid="CR64">
       64
      </xref>
      ,
      <xref ref-type="bibr" rid="CR65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     .
    </p>
    <p id="Par11">
     Hakukuwa na tofauti katika usambazaji wa tofauti kulingana na eneo lao, aina ya ubadilishaji wa nucleotide na uwezekano wa kusababisha magonjwa (Fig.
     <xref ref-type="fig" rid="Fig1">
      1i
     </xref>
     , Jedwali la Nyongeza
     <xref ref-type="supplementary-material" rid="MOESM1">
      5
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      6
     </xref>
     ). Watu wanne (3 wa ART na 1 wa SC) walibeba tofauti ya tRNA ya heteroplasmic inayothibitishwa kuwa na magonjwa, ikijumuisha tofauti m.3243 A &gt; G na m.5521 G &gt; A (zote zinahusishwa na ugonjwa wa MELAS/MERRF), na m.5703 G &gt; A (inayohusishwa na myopathy ya mitochondrial na MERRF). Ili kuzingatia mzigo wa heteroplasmic na kupunguza ugumu wa data kutokana na eneo tofauti la tofauti, tuliongeza mizigo ya tofauti za heteroplasmic kwa kila mtu, zilizoorodheshwa kwa eneo (HV, tRNA, nk). Hii ilisababisha matrisia ya "jumla ya mizigo ya heteroplasmic" kwa kila mtu, kwa kila eneo. Watu wa ART na SC hawakutofautiana katika jumla ya wastani ya mizigo ya heteroplasmic kwa eneo katika mtDNA yao (Fig.
     <xref ref-type="fig" rid="Fig1">
      1j
     </xref>
     , Jedwali la Nyongeza
     <xref ref-type="supplementary-material" rid="MOESM1">
      7
     </xref>
     ). Kisha, tulitumia uchambuzi wa sababu za uchunguzi uliozungushwa kwa njia ya orthogonal kwenye jumla ya mizigo ya heteroplasmic ya kila eneo katika mtDNA kwa kila mtu. Hii ilipunguza zaidi ugumu wa data hadi sababu nne; matrisia ya vipengele inaweza kupatikana katika Fig.
     <xref ref-type="fig" rid="Fig1">
      1k
     </xref>
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
      ,
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
      <xref ref-type="bibr" rid="CR69">
       69
      </xref>
     </sup>
     . Sababu hizi zinaonyesha ushirikiano kati ya aina za tofauti za mtDNA, kama inavyowakilishwa na hypercube katika Fig.
     <xref ref-type="fig" rid="Fig1">
      1l
     </xref>
     <sup/>
     . Tulitoa alama kwa kila sababu kwa sampuli zote na kutumia hizi kuchunguza zaidi utofauti katika muundo wa tofauti za heteroplasmic katika makundi mawili. Watu wa ART walionekana kuwa na alama za juu zaidi katika sababu ya 2, inayosababishwa na uwepo wa tofauti za msimbo wa protini na rRNA na ukosefu wa HV, OHR, TAS na tofauti zisizo na msimbo, ikilinganishwa na watoto wa SC. Sababu 1, 3 na 4 hazikuwa tofauti kati ya makundi mawili (Fig.
     <xref ref-type="fig" rid="Fig1">
      1m
     </xref>
     ). Hii inapendekeza kwamba watu waliozaliwa baada ya ART wana uwezekano mkubwa wa kubeba tofauti za heteroplasmic katika maeneo ya msimbo wa protini na/au rRNA, pamoja na tofauti chache za heteroplasmic katika maeneo mengine ikilinganishwa na wenzao wa SC. Hii inalingana na mwelekeo (usio wa kitakwimu) wa watu wa ART kuwa na idadi kubwa ya tofauti zisizo za synonymous (Fig.
     <xref ref-type="fig" rid="Fig1">
      1h
     </xref>
     ) na mzigo wa wastani wa heteroplasmic katika eneo la HV (ART: 4.55%, SC: 7.02%, Fig.
     <xref ref-type="fig" rid="Fig1">
      1j
     </xref>
     ), na inaonyesha jinsi uchambuzi wa sababu unavyotoa mwingiliano muhimu kati ya vigezo ambavyo uchambuzi wa univariate usingegundua.
    </p>
   </sec>
   <sec id="Sec4">
    <title>
     Tofauti katika wasifu wa mabadiliko ya mtDNA yanahusiana na asilimia za uzito wa kuzaliwa
    </title>
    <p id="Par12">
     Tulichunguza uhusiano kati ya uzito wa kuzaliwa wa watu 388 na wasifu wao wa mtDNA (watu 164 wa SC na 224 wa ART). Uzito wa kuzaliwa ulirekebishwa kwa umri wa ujauzito na jinsia na kuorodheshwa kama chini au juu ya asilimia ya 10 (&lt;P10), ambapo &lt;P10 inachukuliwa kuwa ndogo kwa umri wa ujauzito, na chini au juu ya asilimia ya 25 (&lt;P25).
    </p>
    <p id="Par13">
     Kwanza, tuliuliza seti yetu ya data kwa anuwai ambazo zimeripotiwa kuhusishwa na uzito wa kuzaliwa
     <sup>
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="CR45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
     </sup>
     . Seti yetu ya data haikuwa na watu waliobeba anuwai zilizoripotiwa katika marejeo.
     <sup>
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
     </sup>
     . Kuhusu anuwai m.16189T, ambayo imehusishwa na wembamba wakati wa kuzaliwa, watu 57 katika kundi letu la utafiti walibeba anuwai hii kama homoplasmy (mara nyingi kama sehemu ya haplogroup yao) au kama heteroplasmy. Hata hivyo, haikuhusishwa na uzito wa kuzaliwa chini ya asilimia ya 10 au 25 katika kundi letu la utafiti (Data haikuonyeshwa, mtihani wa Chi-square,
     <italic>
      p
     </italic>
     = 1 na
     <italic>
      p
     </italic>
     = 0.851). Matokeo haya hayakubadilika kwa umuhimu ikiwa tunazingatia anuwai tu wakati ipo nje ya haplogroup au kama heteroplasmy. Zaidi ya hayo, haplogroup T, ambayo imehusishwa na unene, ilionyesha mwelekeo wa kuwa chini ya uwakilishi kwa watu walio chini ya asilimia ya 10 na 25 ya uzito wa kuzaliwa (
     <italic>
      p
     </italic>
     = 0.094 na
     <italic>
      p
     </italic>
     = 0.04, mtawalia, hata hivyo, thamani hizi si muhimu baada ya marekebisho ya Bonferroni kwa majaribio mengi, Fig.
     <xref ref-type="fig" rid="Fig2">
      2a
     </xref>
     ,
     <xref ref-type="fig" rid="Fig2">
      b
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      8
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      S9
     </xref>
     ). Hakukuwa na uhusiano kati ya haplogroup nyingine na asilimia ya uzito wa kuzaliwa wala na uwepo wa anuwai za homoplasmic (Fig.
     <xref ref-type="fig" rid="Fig2">
      2c
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      10
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      11
     </xref>
     ), bila kujali njia ya mimba
     <sup>
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      <xref ref-type="bibr" rid="CR45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
     </sup>
     .
     <fig id="Fig2" position="float">
      <label>
       Fig. 2
      </label>
      <caption xml:lang="en">
       <title>
        Tofauti katika muundo wa tofauti za mtDNA zinahusishwa na asilimia ya uzito wa kuzaliwa kwa watu wa SC.
       </title>
       <p>
        <bold>
         a
        </bold>
        ,
        <bold>
         b
        </bold>
        Hakuna tofauti kubwa katika usambazaji wa haplogrupu na subhaplogrupu katika asilimia za uzito wa kuzaliwa, jaribio sahihi la Fisher lenye marekebisho ya Bonferroni.
        <bold>
         c
        </bold>
        Hakuna tofauti kubwa katika asilimia za watu wanaobeba tofauti za homoplasmic katika maeneo tofauti na kuorodheshwa kulingana na asilimia yao ya uzito wa kuzaliwa, jaribio sahihi la Fisher lenye marekebisho ya Bonferroni.
        <bold>
         d
        </bold>
        Alama za kipengele cha 2 kwa watoto wa ART na SC walioorodheshwa kulingana na asilimia yao ya uzito wa kuzaliwa. jaribio la Mann–Whitney U lenye pande mbili, *
        <italic>
         p
        </italic>
        = 0.04 na **
        <italic>
         p
        </italic>
        = 0.003,
        <italic>
         n
        </italic>
        ART
       </p>
      </caption>
     </fig>
    </p>
    <p id="Par14">
     Kinyume chake, watu wa SC ambao walikuwa &lt;P10 au &lt;P25 walikuwa na alama za juu zaidi katika kipengele cha 2 cha uchambuzi wa anuwai za heteroplasmic kuliko watoto waliozaliwa katika &gt;P10 au &gt;P25 (Fig.
     <xref ref-type="fig" rid="Fig2">
      2d
     </xref>
     ). Sambamba na hili, kama kipengele cha 2 kinavyoendeshwa na anuwai za rRNA na zisizo za kisanisi, watu wa SC wenye uzito wa chini wa kuzaliwa mara nyingi walibeba anuwai zisizo za kisanisi na za rRNA, wakati hakuna tofauti zilizoonekana kwa anuwai nyingine (&lt;P10: 66.6% na &gt;P10: 25.2%, mtihani sahihi wa Fisher,
     <italic>
      p
     </italic>
     = 0.014, &lt;P25: 53.8% na &gt;P25: 22.5%, mtihani sahihi wa Fisher,
     <italic>
      p
     </italic>
     = 0.003, Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      12
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      13
     </xref>
     ). Watoto wa SC &lt;P10 na &lt;P25 pia walibeba mizigo ya juu ya heteroplasmic ya anuwai za rRNA (Fig.
     <xref ref-type="fig" rid="Fig2">
      2e
     </xref>
     ), za anuwai zisizo za kisanisi (Fig.
     <xref ref-type="fig" rid="Fig2">
      2e
     </xref>
     ) na za anuwai zisizo za kisanisi na rRNA kwa pamoja (&lt;P10
     <italic>
      p
     </italic>
     = 0.011, &lt;P25
     <italic>
      p
     </italic>
     = 0.001, Fig.
     <xref ref-type="fig" rid="Fig2">
      2e
     </xref>
     ). Kwa kushangaza, tofauti hizi hazikuonekana kwa watu wa ART (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      14
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      15
     </xref>
     ). Ili kubaini ni vigezo vingine vilivyoweza kuathiri matokeo, kwanza tuligawanya sampuli kwa jinsia (Fig.
     <xref ref-type="fig" rid="Fig2">
      2f
     </xref>
     ,
     <xref ref-type="fig" rid="Fig2">
      g
     </xref>
     ). Ugawaji huu ulisababisha wanawake wa SC &lt;P25 kuwa na matukio ya juu zaidi ya anuwai zisizo za kisanisi na za rRNA (
     <italic>
      p
     </italic>
     = 0.012), wakati wanaume wa SC &lt;P25 na wanawake na wanaume wa SC &lt;P10 walionyesha matukio ya juu zaidi na thamani za p za 0.098, 0.087 na 0.093, mtawalia. Katika kundi la ART, ni wanawake wa ART &lt;P25 pekee waliokuwa na matukio ya juu kidogo lakini si muhimu ya anuwai zisizo za kisanisi na za rRNA (
     <italic>
      p
     </italic>
     = 0.2075, Fig.
     <xref ref-type="fig" rid="Fig2">
      2
     </xref>
     f,
     <xref ref-type="fig" rid="Fig2">
      g
     </xref>
     ). Kigezo kingine kinachowezekana katika kundi letu ni vyombo mbalimbali vya utamaduni wa kiinitete ambavyo viinitete vilifichuliwa. Kundi letu la utafiti linashirikiana kwa sehemu na utafiti unaoonyesha kwamba viinitete vilivyokuzwa katika vyombo vya Cook® vina uzito wa chini wa kuzaliwa, na kwamba viinitete vya kiume ni nyeti zaidi kwa athari hii
     <sup>
      <xref ref-type="bibr" rid="CR70">
       70
      </xref>
     </sup>
     . Tunaona mwelekeo sawa katika utafiti wa sasa, ambapo kwa watu ambao walifanyiwa vyombo vya Cook® na UZB (yaani, chombo cha ndani kilichotengenezwa katika UZ Brussel) wanaume huzaliwa mara nyingi zaidi na uzito wa kuzaliwa &lt;P25 kuliko wanawake (Fig.
     <xref ref-type="fig" rid="Fig2">
      2h
     </xref>
     , 25.5% kwa wanaume dhidi ya 10.7% kwa wanawake,
     <italic>
      p
     </italic>
     = 0.0745). Zaidi ya hayo, mmoja tu wa watu hawa wa kiume wa ART &lt;P25 (5%) alibeba anuwai zisizo za kisanisi au za rRNA, ikilinganishwa na 53.8% ya watu wa SC &lt;P25 (Fig.
     <xref ref-type="fig" rid="Fig2">
      2h
     </xref>
     ,
     <italic>
      p
     </italic>
     = 0.001). Kinyume chake, watu ambao walifichuliwa kwa vyombo vya utamaduni wa Vitrolife® walibeba anuwai zisizo za kisanisi na za rRNA katika 50% ya kesi, sawa na watu wa SC &lt;P25 (Fig.
     <xref ref-type="fig" rid="Fig2">
      2h
     </xref>
     ). Matokeo haya yanapendekeza kwamba athari ya kufichuliwa kwa vyombo vya Cook® au UZB inazidi athari yoyote ya mazingira ya mtDNA. Kwa hiyo, katika uchambuzi zaidi, tuliondoa watu wa ART waliofichuliwa kwa vyombo vya Cook® na UZB na tukachambua tena vigezo vyote vinavyohusiana na mtDNA kwa watu wa SC na ART waliofichuliwa kwa vyombo vya Vitrolife® pekee. Hakukuwa na uhusiano kati ya (sub)haplogroup na asilimia ya uzito wa kuzaliwa (Fig.
     <xref ref-type="fig" rid="Fig3">
      3a
     </xref>
     ,
     <xref ref-type="fig" rid="Fig3">
      b
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      16
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      17
     </xref>
     ) wala na uwepo wa anuwai za homoplasmic, isipokuwa homoplasmies za tRNA, ambazo zilikuwa za kawaida zaidi kwa watu &lt;P10 (29.4% dhidi ya 6.4%, Fig.
     <xref ref-type="fig" rid="Fig3">
      3c
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      18
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      19
     </xref>
     ). Wakati wa kuangalia anuwai za heteroplasmic, watu &lt;P25 na &lt;P10 mara nyingi walibeba anuwai za protini zisizo za kisanisi na za rRNA, lakini kufikia umuhimu wa takwimu tu kwa anuwai zisizo za kisanisi kwa watu &lt;P25 (Fig.
     <xref ref-type="fig" rid="Fig3">
      3d
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      20
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      21
     </xref>
     ). Kama katika kesi nyingi anuwai zisizo za kisanisi hazikujulikana kuhusishwa na ugonjwa wa mitochondrial, tuliwaainisha ikiwa kulikuwa na ushahidi zaidi wa kuunga mkono uwezekano wao wa kuwa na ugonjwa. Anuwai kumi na tano (18.75%) zilikuwa na alama ya MutPred2 zaidi ya 0.61 na anuwai arobaini na sita (57.7%) zilikuwa na masafa yaliyoripotiwa chini ya 0.002 katika MITOMAP (mitomap.org), kizingiti ambacho kimependekezwa kama ushahidi wa kuunga mkono uwezekano wa ugonjwa
     <sup>
      <xref ref-type="bibr" rid="CR71">
       71
      </xref>
      <xref ref-type="bibr" rid="CR72">
       72
      </xref>
      <xref ref-type="bibr" rid="CR73">
       73
      </xref>
     </sup>
     . Tukichukua alama za MutPred2 na masafa ya MITOMAP pamoja, 50 kati ya anuwai 80 zisizo za kisanisi zilizotambuliwa zina ushahidi wa kuunga mkono uwezekano wa kuwa na ugonjwa (62.5%, Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM4">
      1
     </xref>
     ). Ulinganisho wa matukio yao kwa watu walio chini na juu ya P25 haukuonyesha tofauti za takwimu, labda kutokana na ukubwa mdogo wa sampuli (21% katika &lt;P25, 14% katika &gt;P25, mtihani sahihi wa Fisher,
     <italic>
      p
     </italic>
     = 0.270), na hatukufanya uchambuzi zaidi wa mgawanyiko huu wa anuwai katika uchambuzi uliofuata. Kuchanganya anuwai zisizo za kisanisi na za rRNA kunaonyesha kwamba 52.9% ya watu &lt;P10 na 52.1% ya watu &lt;P25 wanabeba angalau moja ya anuwai hizo (vs &gt;P10: 31.3% na &gt;P25: 28.6%, Fig.
     <xref ref-type="fig" rid="Fig3">
      3e
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      20
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      21
     </xref>
     ). Zaidi ya hayo, watu wa SC na Vitrolife®-ART wenye uzito wa kuzaliwa &lt;P10 na &lt;P25 walikuwa na mizigo ya juu zaidi ya heteroplasmic ya anuwai zisizo za kisanisi na za rRNA (Fig.
     <xref ref-type="fig" rid="Fig3">
      3f
     </xref>
     ).
     <fig id="Fig3" position="float">
      <label>
       Fig. 3
      </label>
      <caption xml:lang="en">
       <title>
        Watu waliozaliwa kwa uzazi wa kawaida na ART walioathiriwa na Vitrolife culture medium wana uwezekano mkubwa wa kubeba tofauti za non-synonymous na rRNA.
       </title>
       <p>
        <bold>
         a
        </bold>
        ,
        <bold>
         b
        </bold>
        Uenezi wa haplogrupu na subhaplogrupu, mtawalia, kati ya watu wa SC na ART walioathiriwa na Vitrolife® culture medium, waliowekwa katika makundi kulingana na asilimia ya uzito wa kuzaliwa. Jaribio la Fisher-exact lenye pande mbili, hakuna tofauti kubwa zilizopatikana baada ya marekebisho ya Bonferroni (
        <italic>
         p
        </italic>
        values ≤ 0.007 zilizingatiwa kuwa muhimu).
        <bold>
         c
        </bold>
        Asilimia ya watu wa SC na ART walioathiriwa na Vitrolife® culture medium wanaobeba tofauti za homoplasmic katika maeneo tofauti na waliowekwa katika makundi kulingana na asilimia ya uzito wa kuzaliwa. Homoplasmies katika maeneo ya tRNA yalipatikana mara nyingi zaidi kwa watoto wenye uzito wa kuzaliwa &lt;P10 (29.4% vs 6.4%, jaribio la Fisher’s exact lenye pande mbili na marekebisho ya Bonferroni,
        <italic>
         p
        </italic>
        = 0.006 (
        <italic>
         p
        </italic>
        values ≤ 0.00625 zilizingatiwa kuwa muhimu)).
        <bold>
         d
        </bold>
        Idadi ya watu wa SC na ART walioathiriwa na Vitrolife® culture medium, waliowekwa katika makundi kulingana na asilimia ya uzito wa kuzaliwa chini au juu ya P10 au P25, wanaobeba tofauti za non-synonymous protein-coding au rRNA loci. Watoto waliozaliwa na uzito wa kuzaliwa &lt;P25 mara nyingi walibeba tofauti za non-synonymous protein-coding (37.5% vs 29.5%, jaribio la Fisher’s exact lenye pande mbili, *
        <italic>
         p
        </italic>
        = 0.015).
        <bold>
         e
        </bold>
        Idadi ya watu wa SC na ART walioathiriwa na Vitrolife® culture medium, waliowekwa katika makundi kulingana na asilimia ya uzito wa kuzaliwa chini au juu ya P10 au P25, wanaobeba tofauti za non-synonymous protein coding na/au rRNA loci. 52.9% ya &lt;P10 na 52.1% ya &lt;P25 watu wanabeba angalau moja ya tofauti hizo (vs &gt;P10: 31.3%, jaribio la Fisher’s exact lenye pande mbili,
        <italic>
         p
        </italic>
        = 0.106, &gt;P25: 28.6%, jaribio la Fisher’s exact, **
        <italic>
         p
        </italic>
        = 0.002).
        <bold>
         f
        </bold>
        Jumla ya mizigo ya watu wa SC na ART walioathiriwa na Vitrolife® culture medium chini au juu ya P10 na P25 wanaobeba tofauti za non-synonymous protein coding na rRNA. &lt;P10 na &lt;P25 walikuwa na jumla ya mizigo ya heteroplasmic ya non-synonymous na rRNA variants (jaribio la Mann–Whitney U lenye pande mbili,
        <italic>
         p
        </italic>
        = 0.077 na **
        <italic>
         p
        </italic>
        = 0.003, mtawalia).
        <italic>
         n
        </italic>
        &lt; P10 = 17 watu,
        <italic>
         n
        </italic>
        &gt; P10 = 265 watu,
        <italic>
         n
        </italic>
        &lt; P25 = 48 watu,
        <italic>
         n
        </italic>
        &gt; P25 = 234 watu. Mipira ya usawa katika paneli inawakilisha wastani wa thamani katika mchoro wa kutawanya, kila nukta inawakilisha sampuli. # thamani ya
        <italic>
         p
        </italic>
        muhimu baada ya marekebisho ya Bonferroni, +
        <italic>
         p
        </italic>
        &lt; 0.2, ilijumuishwa katika urejeshaji wa binary logistic regression. Data ya chanzo imetolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig3_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
    </p>
    <p id="Par15">
     Kisha, tulitumia usajili wa binary logistic ili kusoma athari za vigezo tofauti vinavyohusiana na mtDNA kwenye uzito wa kuzaliwa, ikiwa ni pamoja na vigezo vinavyoweza kuchanganya vilivyoorodheshwa katika Jedwali
     <xref ref-type="table" rid="Tab1">
      1
     </xref>
     <sup/>
     . Tulitumia njia mbili: kwanza, tulijumuisha kigezo chochote cha mtDNA kilichoonyesha uhusiano na asilimia ya uzito wa kuzaliwa kupitia uchambuzi wa univariate na
     <italic>
      p
     </italic>
     &lt; 0.2 katika mfano, isipokuwa uwepo wa homoplasmies za TAS kwa sababu zilikuwepo kwa watu 3 tu wa kundi (Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM5">
      2
     </xref>
     ). Pili, tulijaribu njia ya kurudi nyuma, ambapo tulianzisha vigezo vyote vilivyoorodheshwa katika Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM5">
      2
     </xref>
     <sup/>
     . Kwa watu &lt;P10, vigezo vifuatavyo vilionyesha athari muhimu ya takwimu kwenye uzito wa kuzaliwa: uvutaji sigara wakati wa ujauzito, shinikizo la damu wakati wa ujauzito, uwepo wa homoplasmies za tRNA nje ya haplogroup ya mtu na uwepo wa anuwai zinazohusishwa na haplogroup K1 (Jedwali
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ). Vigezo hivi hivyo pia vilipatikana kuhusishwa kwa kiasi kikubwa na uzito wa kuzaliwa, isipokuwa anuwai zinazohusishwa na haplogroup K1 (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      22
     </xref>
     ). Katika kesi ya watu &lt;P25, usajili wa logistic ulisababisha mfano unaojumuisha haplogroups I, J na T, umri wa mama, uwepo wa homoplasmies za tRNA nje ya haplogroup ya mtu na uwepo wa anuwai za protini zisizo za kisanisi na za rRNA. Ni haplogroup I pekee, umri wa mama na uwepo wa anuwai zisizo za kisanisi na za rRNA zilikuwa na athari muhimu ya takwimu katika kuongeza nafasi za kuzaliwa &lt;P25 (Jedwali
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ). Mfano wa kurudi nyuma ulidumisha umri wa mama na uwepo wa anuwai zisizo za kisanisi na za rRNA kama zinavyohusishwa kwa kiasi kikubwa na uzito wa kuzaliwa &lt;P25 (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      23
     </xref>
     ). Ingawa usajili wa logistic ulitambua vigezo vilivyokuwa na athari muhimu ya takwimu kwenye utabiri wa asilimia ya uzito wa kuzaliwa, mifano iliyotengenezwa na usajili haikuwa na ufanisi katika kutabiri ikiwa mtu atakuwa na uzito wa kuzaliwa &lt;P10 au &lt;P25. Katika kundi la &lt;P10, ni mtu 1 tu kati ya 13 aliyeainishwa kwa usahihi, ilhali katika kundi la &lt;P25, kulikuwa na watu 4 kati ya 42. Kwa hiyo, tulitengeneza mfano wa ziada kulingana na mbinu ya uchambuzi wa kutofautisha. Tulijenga mifano mitatu: ya kwanza ikitumia tu vigezo vinavyohusiana na ujauzito (umri wa mama, uvutaji sigara, shinikizo la damu wakati wa ujauzito, BMI ya mama &gt; 25, primiparity na kisukari cha ujauzito), ya pili ikitumia tu vigezo vya mtDNA vinavyohusishwa na matokeo ya asilimia ya uzito wa kuzaliwa na
     <italic>
      p
     </italic>
     &lt; 0.2, na mfano wa tatu ukijumuisha vyote (Jedwali
     <xref ref-type="table" rid="Tab3">
      3
     </xref>
     na
     <xref ref-type="table" rid="Tab4">
      4
     </xref>
     ). Mifano ya kutabiri &lt;P10 na &lt;P25 ilionyesha kwamba, wakati vigezo vinavyohusiana na ujauzito peke yake vilikuwa watabiri wazuri sana wa asilimia ya uzito wa kuzaliwa, kuongezwa kwa vigezo vya mtDNA kuliongeza uwezo wa mfano kutambua kwa usahihi watu &lt;P10 na &lt;P25. Kwa mfano wa &lt;P10, kuongezwa kwa vigezo vya mtDNA kuliongeza usahihi kwa kiasi kikubwa kwa kutambua watu &lt;P10 kutoka 40% hadi 70%. Kwa &lt;P25, usahihi uliongezeka kwa kiasi kidogo kutoka 58.1% hadi 67.7%. Kwa kushangaza, vigezo vya mtDNA peke yake vilikuwa na utabiri zaidi kwa uzito wa kuzaliwa &lt;P25 kuliko vigezo vinavyohusiana na ujauzito (64.9% dhidi ya 62.5% uainishaji sahihi, mtawalia).
     <table-wrap id="Tab2">
      <label>
       Jedwali 2
      </label>
      <caption xml:lang="en">
       <p>
        Utabiri wa usajili wa binary logistic wa uzito wa kuzaliwa chini ya asilimia ya 10 au 25 kwa watu wa SC na watu wa ART walioathiriwa na utamaduni wa Vitrolife®
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th/>
         <th>
          <p>
           Exp(B)
          </p>
         </th>
         <th>
          <p>
           95% C.I. kwa Exp(B)
          </p>
         </th>
         <th>
          <p>
           Umuhimu
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            P10 katika SC na ART Vitrolife®
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuvuta sigara
          </p>
         </td>
         <td>
          <p>
           7.211
          </p>
         </td>
         <td>
          <p>
           1.552–33.496
          </p>
         </td>
         <td>
          <p>
           0.012
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Shinikizo la damu wakati wa ujauzito
          </p>
         </td>
         <td>
          <p>
           14.045
          </p>
         </td>
         <td>
          <p>
           1.185–166.410
          </p>
         </td>
         <td>
          <p>
           0.036
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup K1
          </p>
         </td>
         <td>
          <p>
           4.952
          </p>
         </td>
         <td>
          <p>
           1.075–22.813
          </p>
         </td>
         <td>
          <p>
           0.040
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           tRNA homoplasmies
          </p>
         </td>
         <td>
          <p>
           7.518
          </p>
         </td>
         <td>
          <p>
           1.850–30.553
          </p>
         </td>
         <td>
          <p>
           0.005
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Heteroplasmic non-synonymous na rRNA variants
          </p>
         </td>
         <td>
          <p>
           2.180
          </p>
         </td>
         <td>
          <p>
           642–7.400
          </p>
         </td>
         <td>
          <p>
           0.212
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            P25 katika SC na ART Vitrolife
           </bold>
           ®
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           1.129
          </p>
         </td>
         <td>
          <p>
           1.036–1.231
          </p>
         </td>
         <td>
          <p>
           0.006
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup I
          </p>
         </td>
         <td>
          <p>
           5.774
          </p>
         </td>
         <td>
          <p>
           1.125–29.624
          </p>
         </td>
         <td>
          <p>
           0.035
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup J
          </p>
         </td>
         <td>
          <p>
           2.248
          </p>
         </td>
         <td>
          <p>
           0.783–6.455
          </p>
         </td>
         <td>
          <p>
           0.132
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup T
          </p>
         </td>
         <td>
          <p>
           0.146
          </p>
         </td>
         <td>
          <p>
           0.018–1.165
          </p>
         </td>
         <td>
          <p>
           0.069
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           tRNA homoplasmies
          </p>
         </td>
         <td>
          <p>
           2.405
          </p>
         </td>
         <td>
          <p>
           0.796–7.264
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Heteroplasmic non-synonymous na rRNA variants
          </p>
         </td>
         <td>
          <p>
           2.974
          </p>
         </td>
         <td>
          <p>
           1.439–6.2144
          </p>
         </td>
         <td>
          <p>
           0.003
          </p>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
     <table-wrap id="Tab3">
      <label>
       Jedwali 3
      </label>
      <caption xml:lang="en">
       <p>
        Uchambuzi wa kutofautisha kutabiri uzito wa kuzaliwa chini ya asilimia 10 kwa watu wa SC na watu wa ART walioathiriwa na Vitrolife® culture medium
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th>
          <p>
           Vipengele vilivyojumuishwa kwenye mfano
          </p>
         </th>
         <th colspan="2">
          <p>
           Viwango vya Kawaida vya Kazi ya Kutofautisha
          </p>
         </th>
         <th>
          <p>
           Wilks’ Lambda
          </p>
          <p>
           <italic>
            N
           </italic>
           = idadi ya kesi zilizojumuishwa kwenye mfano
          </p>
         </th>
         <th>
          <p>
           Imekadiriwa kwa usahihi (asili dhidi ya kesi zilizojaribiwa tena)
          </p>
          <p>
           Imekadiriwa kwa usahihi katika kila kategoria
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td rowspan="6">
          <p>
           Vipengele vyote vinavyohusiana na ujauzito
          </p>
         </td>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.249
          </p>
         </td>
         <td rowspan="6">
          <p>
           <italic>
            P
           </italic>
           = 0.010
          </p>
          <p>
           <italic>
            N
           </italic>
           = 200
          </p>
         </td>
         <td rowspan="6">
          <p>
           89.0% dhidi ya 87.0%
          </p>
          <p>
           90.5% &gt;P10 sahihi
          </p>
          <p>
           40% &lt;P10 sahihi
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Uvutaji sigara
          </p>
         </td>
         <td>
          <p>
           0.756
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Shinikizo la damu wakati wa ujauzito
          </p>
         </td>
         <td>
          <p>
           0.596
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           BMI ya mama &gt; 25
          </p>
         </td>
         <td>
          <p>
           −0.509
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Primiparity
          </p>
         </td>
         <td>
          <p>
           0.132
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kisukari cha ujauzito
          </p>
         </td>
         <td>
          <p>
           0.001
          </p>
         </td>
        </tr>
        <tr>
         <td rowspan="3">
          <p>
           Vipengele vya mtDNA pekee
          </p>
         </td>
         <td>
          <p>
           Tofauti za tRNA za homoplasmic
          </p>
         </td>
         <td>
          <p>
           0.817
          </p>
         </td>
         <td rowspan="3">
          <p>
           <italic>
            P
           </italic>
           &lt; 0.001
          </p>
          <p>
           <italic>
            N
           </italic>
           = 282
          </p>
         </td>
         <td rowspan="3">
          <p>
           84.0% dhidi ya 84.0%
          </p>
          <p>
           87.2% &gt;P10 sahihi
          </p>
          <p>
           35.5% &lt;P10 sahihi
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tofauti za heteroplasmic zisizo za kisanisi na rRNA
          </p>
         </td>
         <td>
          <p>
           0.764
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup K1
          </p>
         </td>
         <td>
          <p>
           0.302
          </p>
         </td>
        </tr>
        <tr>
         <td rowspan="9">
          <p>
           Vipengele vya ujauzito na mtDNA
          </p>
         </td>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.221
          </p>
         </td>
         <td rowspan="9">
          <p>
           <italic>
            P
           </italic>
           &lt; 0.001
          </p>
          <p>
           <italic>
            N
           </italic>
           = 200
          </p>
         </td>
         <td rowspan="9">
          <p>
           87.0%% dhidi ya 86.0%
          </p>
          <p>
           87.9% &gt;P10 sahihi
          </p>
          <p>
           70.0% &lt;P10 sahihi
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Uvutaji sigara
          </p>
         </td>
         <td>
          <p>
           0.569
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Shinikizo la damu wakati wa ujauzito
          </p>
         </td>
         <td>
          <p>
           0.462
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           BMI ya mama &gt; 25
          </p>
         </td>
         <td>
          <p>
           −0.362
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kisukari cha ujauzito
          </p>
         </td>
         <td>
          <p>
           0.043
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Primiparity
          </p>
         </td>
         <td>
          <p>
           0.076
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tofauti za tRNA za homoplasmic
          </p>
         </td>
         <td>
          <p>
           0.700
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tofauti za heteroplasmic zisizo za kisanisi na rRNA
          </p>
         </td>
         <td>
          <p>
           0.179
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup K1
          </p>
         </td>
         <td>
          <p>
           0.233
          </p>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
     <table-wrap id="Tab4">
      <label>
       Jedwali 4
      </label>
      <caption xml:lang="en">
       <p>
        Uchambuzi wa kutofautisha kutabiri uzito wa kuzaliwa chini ya asilimia 25 kwa watu wa SC na ART walioathiriwa na Vitrolife® culture medium
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th>
          <p>
           Vipengele vilivyojumuishwa kwenye mfano
          </p>
         </th>
         <th colspan="2">
          <p>
           Viwango vya Kawaida vya Kazi ya Kutofautisha
          </p>
         </th>
         <th>
          <p>
           Wilks’ Lambda
          </p>
          <p>
           <italic>
            N
           </italic>
           = idadi ya kesi zilizojumuishwa kwenye mfano
          </p>
         </th>
         <th>
          <p>
           Imekadiriwa kwa usahihi (asili dhidi ya kesi zilizojaribiwa tena)
          </p>
          <p>
           Imekadiriwa kwa usahihi katika kila kategoria
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td rowspan="6">
          <p>
           Vipengele vyote vinavyohusiana na ujauzito
          </p>
         </td>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.871
          </p>
         </td>
         <td rowspan="6">
          <p>
           <italic>
            P
           </italic>
           = 0.174
          </p>
          <p>
           <italic>
            N
           </italic>
           = 200
          </p>
         </td>
         <td rowspan="6">
          <p>
           62.5% dhidi ya 59.5%
          </p>
          <p>
           63.3% &gt;P25 sahihi
          </p>
          <p>
           58.1% &lt;P25 sahihi
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Uvutaji sigara
          </p>
         </td>
         <td>
          <p>
           0.412
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Shinikizo la damu wakati wa ujauzito
          </p>
         </td>
         <td>
          <p>
           0.392
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           BMI ya mama &gt; 25
          </p>
         </td>
         <td>
          <p>
           −0.109
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Primiparity
          </p>
         </td>
         <td>
          <p>
           0.132
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kisukari cha ujauzito
          </p>
         </td>
         <td>
          <p>
           −0.093
          </p>
         </td>
        </tr>
        <tr>
         <td rowspan="5">
          <p>
           Vipengele vya mtDNA pekee
          </p>
         </td>
         <td>
          <p>
           Tofauti za tRNA za homoplasmic
          </p>
         </td>
         <td>
          <p>
           0.369
          </p>
         </td>
         <td rowspan="5">
          <p>
           <italic>
            P
           </italic>
           &lt; 0.001
          </p>
          <p>
           <italic>
            N
           </italic>
           = 282
          </p>
         </td>
         <td rowspan="5">
          <p>
           64.9% dhidi ya 64.9%%
          </p>
          <p>
           64.5% &gt;P25 sahihi
          </p>
          <p>
           66.7% &lt;P25 sahihi
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tofauti za heteroplasmic zisizo za kisanisi na rRNA
          </p>
         </td>
         <td>
          <p>
           0.681
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup I
          </p>
         </td>
         <td>
          <p>
           0.411
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup J
          </p>
         </td>
         <td>
          <p>
           0.343
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup T
          </p>
         </td>
         <td>
          <p>
           −0.398
          </p>
         </td>
        </tr>
        <tr>
         <td rowspan="11">
          <p>
           Vipengele vya ujauzito na mtDNA
          </p>
         </td>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.565
          </p>
         </td>
         <td rowspan="11">
          <p>
           <italic>
            P
           </italic>
           &lt; 0.046
          </p>
          <p>
           <italic>
            N
           </italic>
           = 200
          </p>
         </td>
         <td rowspan="11">
          <p>
           68.5%% dhidi ya 63.0%
          </p>
          <p>
           68.6% &gt;P25 sahihi
          </p>
          <p>
           67.7% &lt;P25 sahihi
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Uvutaji sigara
          </p>
         </td>
         <td>
          <p>
           0.326
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Shinikizo la damu wakati wa ujauzito
          </p>
         </td>
         <td>
          <p>
           0.217
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           BMI ya mama &gt; 25
          </p>
         </td>
         <td>
          <p>
           −0.102
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kisukari cha ujauzito
          </p>
         </td>
         <td>
          <p>
           −0.022
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Primiparity
          </p>
         </td>
         <td>
          <p>
           0.115
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tofauti za tRNA za homoplasmic
          </p>
         </td>
         <td>
          <p>
           0.333
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup I
          </p>
         </td>
         <td>
          <p>
           0.218
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup J
          </p>
         </td>
         <td>
          <p>
           0.236
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Haplogroup T
          </p>
         </td>
         <td>
          <p>
           −0.325
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Tofauti za heteroplasmic zisizo za kisanisi na rRNA
          </p>
         </td>
         <td>
          <p>
           0.531
          </p>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
    </p>
   </sec>
   <sec id="Sec5">
    <title>
     Watu wa ART mara nyingi huonyesha mabadiliko mapya yasiyo ya kinasaba kuliko wenzao waliozaliwa kwa njia ya kawaida
    </title>
    <p id="Par16">
     Ili kuchunguza asili ya tofauti hizi katika mtDNA, tulisoma jenomu ya mitochondrial ya jozi za mama na mtoto 67 wa ART na 90 wa SC. Tuliorodhesha anuwai kama "iliyopitishwa" wakati ilikuwepo kwa mama na mtoto, na kama "de novo" wakati anuwai ilikuwa tu kwa mtoto. Kwa jumla, tulipata anuwai 19 zilizopitishwa, na mabadiliko madogo ya jumla katika mzigo wa heteroplasmic ambayo hayakuwa tofauti kati ya watu wa SC na ART (Fig.
     <xref ref-type="fig" rid="Fig4">
      4a
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      24
     </xref>
     ), na anuwai 109 za de novo, 36 kati ya hizo zilikuwa katika maeneo yasiyo ya coding, 54 katika coding ya protini, 8 katika rRNA na 11 katika loci za tRNA (Fig.
     <xref ref-type="fig" rid="Fig4">
      4b
     </xref>
     , Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM6">
      3
     </xref>
     ). Jozi za mama na mtoto wa ART zilikuwa na matukio ya juu zaidi ya anuwai zisizo za kisanisi za de novo kuliko jozi za mama na mtoto wa SC (ART: 38.8% (26/67), SC: 20.0% (18/90), Fig.
     <xref ref-type="fig" rid="Fig4">
      4c
     </xref>
     ). Sambamba na hili, wakati hakukuwa na tofauti katika jumla ya mizigo ya heteroplasmic ya anuwai zilizopitishwa kwa kila mtu (Fig.
     <xref ref-type="fig" rid="Fig4">
      4a
     </xref>
     ), watoto wa ART walionyesha mizigo ya juu ya heteroplasmic ya anuwai zisizo za kisanisi za de novo (Fig.
     <xref ref-type="fig" rid="Fig4">
      4d
     </xref>
     ). Matokeo haya yanapendekeza kwamba tofauti katika anuwai za mtDNA kati ya watoto wa ART na SC zinatokana hasa na upatikanaji wa mara kwa mara wa anuwai zisizo za kisanisi za coding ya protini za de novo kwa watoto wa ART.
     <fig id="Fig4" position="float">
      <label>
       Fig. 4
      </label>
      <caption xml:lang="en">
       <title>
        Watu wa ART wana uwezekano mkubwa wa kubeba tofauti za de novo non-synonymous mtDNA kuliko wenzao waliozaliwa kwa kawaida.
       </title>
       <p>
        <bold>
         a
        </bold>
        Muhtasari wa tofauti za heteroplasmic zilizopitishwa zilizotambuliwa katika jozi za mama na mtoto, zilizowekwa katika makundi kulingana na njia ya mimba na kuwekewa lebo kulingana na eneo lao katika jenomu ya mtDNA. Ukubwa wa kiputo ni sawia na mzigo wa heteroplasmic kwa mama na mtoto wake. Hakuna tofauti kubwa za kitakwimu kati ya SC na ART, jaribio la Mann–Whitney U lenye pande mbili.
        <bold>
         b
        </bold>
        Muhtasari wa tofauti za de novo heteroplasmic zilizotambuliwa katika jozi za mama na mtoto, zilizowekwa katika makundi kulingana na njia ya mimba na kuwekewa lebo kulingana na eneo lao katika jenomu ya mtDNA. Ukubwa wa kiputo ni sawia na mzigo wa heteroplasmic kwa mtoto.
        <bold>
         c
        </bold>
        Idadi ya jozi za mama na mtoto wa ART na SC zinazoonyesha tofauti za de novo non-synonymous na rRNA. Watoto wa ART mara nyingi huonyesha tofauti zaidi za protein coding za de novo kuliko watoto wa SC (jaribio la Fisher’s exact lenye pande mbili, *
        <italic>
         p
        </italic>
        = 0.01).
        <bold>
         d
        </bold>
        Jumla ya mizigo ya heteroplasmic ya tofauti za de novo kwa watu wa ART na SC, waliowekwa katika makundi kwa kila eneo. Jaribio la Mann–Whitney U lenye pande mbili *
        <italic>
         p
        </italic>
        = 0.048,
        <italic>
         n
        </italic>
        ART = 67 watu,
        <italic>
         n
        </italic>
        SC = 90 watu. Mipira ya usawa inawakilisha wastani wa thamani katika mchoro wa kutawanya, kila nukta inawakilisha sampuli. Data ya chanzo imetolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig4_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
    </p>
   </sec>
   <sec id="Sec6">
    <title>
     Umri wa mama na ukubwa wa kundi la oocyte baada ya OS unahusiana vyema na ongezeko la matukio ya mabadiliko mapya ya mtDNA kwa watoto na oocytes
    </title>
    <p id="Par17">
     Tulidhani kwamba utaratibu wa OS unaohusishwa na ART unaweza kusababisha tofauti katika anuwai za de novo zilizozingatiwa kati ya jozi za mama na mtoto wa ART na SC. Ili kujaribu hili, tulilinganisha jenomu ya mitochondrial ya oocytes za ndugu zilizopatikana kutoka kwa mizunguko ya asili ya hedhi au baada ya OS kutoka kwa wanawake 29 vijana (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      25
     </xref>
     ). Tulipanga sehemu kubwa ya mtDNA (12.9 Kbp) ya oocytes 113 za kibinafsi, 48 kutoka kwa mizunguko ya asili na 65 ya mizunguko ya OS, pamoja na vyanzo vitatu vya DNA ya somatic kutoka kwa wafadhili. Hii ilituruhusu kuainisha anuwai za heteroplasmic kama zilizopitishwa (zilizopo katika angalau sampuli mbili za mfadhili yule yule, Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM7">
      4
     </xref>
     ) au de novo (ya kipekee kwa oocyte moja, Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM8">
      5
     </xref>
     ).
    </p>
    <p id="Par18">
     Aina kumi na nne za mabadiliko zilizopitishwa zilitambuliwa katika mayai ya wafadhili saba. Hakuna mwelekeo ulioonekana katika mabadiliko ya mzigo wa heteroplasmic wa aina hiyo katika mayai yaliyopatikana baada ya mzunguko wa asili na OS (Fig.
     <xref ref-type="fig" rid="Fig5">
      5a
     </xref>
     , Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM7">
      4
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      26
     </xref>
     ).
     <fig id="Fig5" position="float">
      <label>
       Fig. 5
      </label>
      <caption xml:lang="en">
       <title>
        Kuzeeka kwa mama na ukubwa wa kundi la oocyte baada ya OS kunahusishwa na uwezekano mkubwa wa tofauti za de novo mtDNA kwa watoto na oocytes.
       </title>
       <p>
        <bold>
         a
        </bold>
        Tofauti za heteroplasmic zilizopitishwa zilizotambuliwa kwa wafadhili wa oocyte na oocytes zao. Ukubwa wa kiputo ni sawia na mzigo wa heteroplasmic wa tofauti katika kila sampuli, ambazo zinajumuisha tishu za mwili na hadi oocytes 3 katika mzunguko wa kawaida na hadi oocytes 7 baada ya OS.
        <bold>
         b
        </bold>
        Usambazaji wa idadi ya oocytes baada ya mizunguko ya kawaida na OS inayoonyesha tofauti za de novo katika maeneo tofauti. Hakuna tofauti kubwa za kitakwimu zilizobainika (majaribio ya Chi-square lenye pande mbili).
        <bold>
         c
        </bold>
        Jumla ya mizigo ya heteroplasmic ya tofauti za de novo katika oocytes baada ya mizunguko ya kawaida na OS, waliowekwa katika makundi kwa kila eneo.
        <italic>
         n
        </italic>
        OS = 65 oocytes,
        <italic>
         n
        </italic>
        Kawaida = 48 oocytes. Mipira ya usawa katika paneli inawakilisha wastani wa thamani katika mchoro wa kutawanya, kila nukta inawakilisha sampuli.
        <bold>
         d
        </bold>
        Jumla ya idadi ya tofauti za de novo katika jozi za mama na mtoto na katika oocytes zilizopangwa dhidi ya umri wa mama wakati wa mimba au ukusanyaji wa oocyte. Urejeshaji wa Poisson Generalized linear model (PGLMR) unaonyesha kuwa kuzeeka kwa mama kunahusiana kwa kiasi kikubwa na jumla ya idadi ya tofauti za de novo katika kizazi kijacho (
        <italic>
         p
        </italic>
        &lt; 0.001).
        <bold>
         e
        </bold>
        Idadi ya tofauti za de novo non-synonymous na rRNA katika oocytes, zilizopangwa dhidi ya umri wa mama wakati wa ukusanyaji wa oocyte. PGLMR inaonyesha kuwa kuzeeka kwa mama hakuhusiani kwa kiasi kikubwa na idadi ya tofauti za de novo non-synonymous na rRNA katika oocytes (
        <italic>
         p
        </italic>
        = 0.07).
        <bold>
         f
        </bold>
        Idadi ya tofauti za de novo non-synonymous na rRNA katika oocytes, zilizopangwa dhidi ya idadi ya oocytes zilizokusanywa katika mzunguko. PGLMR inaonyesha kuwa ukubwa wa kundi la oocyte unahusiana kwa kiasi kikubwa na idadi ya de novo ya tofauti za non-synonymous na rRNA katika oocytes (
        <italic>
         p
        </italic>
        = 0.007). BS: buccal swab, B: damu, U: seli za njia ya mkojo, Katika (
        <bold>
         d
        </bold>
        –
        <bold>
         f
        </bold>
        ), ukubwa wa nukta ni sawia na idadi ya sampuli zilizo na data sawa. Data ya chanzo imetolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig5_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
    </p>
    <p id="Par19">
     Kwa jumla, tulitambua aina 113 za de novo, zilizogawanywa sawa katika mayai ya mzunguko wa asili na mayai ya OS (wastani wa 1.7 na 1.8 aina kwa yai kwa mayai ya asili na OS, mtawalia, Fig.
     <xref ref-type="fig" rid="Fig5">
      5b
     </xref>
     , Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM8">
      5
     </xref>
     ). Pia hakukuwa na tofauti katika eneo la aina hizi za de novo, na mgawanyo sawa kati ya mayai ya asili na OS katika maeneo yasiyo na msimbo na katika loci za rRNA, tRNA na msimbo wa protini (Fig.
     <xref ref-type="fig" rid="Fig5">
      5b
     </xref>
     ). Kwa kufanana na uchambuzi wa awali, tulipunguza ugumu wa data kwa kuunda jumla ya mizigo ya heteroplasmic ya aina za de novo katika kila yai (Fig.
     <xref ref-type="fig" rid="Fig5">
      5c
     </xref>
     ). Hatukupata tofauti kubwa katika mizigo ya heteroplasmic ya mayai ya mzunguko wa asili na OS.
    </p>
    <p id="Par20">
     Hatimaye, tulitumia regression kwa kutumia Mfano wa Poisson Generalized Linear ili kujaribu kama idadi ya aina za de novo katika jozi za mama na mtoto na katika mayai inahusiana na mambo mengine, kama vile umri wa mama wakati wa mimba, vitengo vya FSH vilivyotumika wakati wa OS na ukubwa wa kundi la mayai yaliyopatikana. Kwa mayai, tulitumia wastani wa idadi ya aina za de novo kwa yai kwa kila mfadhili. Vitengo vya FSH havikuhusiana na aina za de novo katika mifano yoyote tuliyojaribu, na viliondolewa zaidi kutoka kwa uchambuzi. Katika kundi linalojumuisha mayai na jozi za mama na mtoto (
     <italic>
      N
     </italic>
     = 170), tuligundua kuwa kuzeeka kwa mama kuliongeza jumla ya idadi ya aina za de novo (Fig.
     <xref ref-type="fig" rid="Fig5">
      5d
     </xref>
     na Jedwali
     <xref ref-type="table" rid="Tab5">
      5
     </xref>
     ) na aina za rRNA (Jedwali
     <xref ref-type="table" rid="Tab5">
      5
     </xref>
     ) lakini si za synonymous au zisizo-synonymous (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      27
     </xref>
     ). Mifano iliyojaribiwa kwenye mayai (
     <italic>
      N
     </italic>
     = 113) ilionyesha kuwa umri wa mama na idadi ya mayai yaliyopatikana baada ya OS inahusiana vyema na jumla ya idadi ya aina za de novo mtDNA katika yai (Fig.
     <xref ref-type="fig" rid="Fig5">
      5
     </xref>
     e,
     <xref ref-type="fig" rid="Fig5">
      f
     </xref>
     , Jedwali
     <xref ref-type="table" rid="Tab5">
      5
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      27
     </xref>
     ). Wakati umri wa mama unahusiana kwa nguvu zaidi na jumla ya idadi ya aina za de novo mtDNA na aina za rRNA, idadi ya mayai yaliyopatikana inahusiana vyema na idadi ya aina za de novo zisizo-synonymous na rRNA katika yai, ikionyesha mbinu mbili tofauti za utekelezaji. Inashangaza, umri wa mama ulikuwa juu zaidi katika kundi la ART (Jedwali
     <xref ref-type="table" rid="Tab1">
      1
     </xref>
     ). Kwa hivyo, mchanganyiko wa kupitia OS na kuwa na umri mkubwa wa mama unaweza kuelezea kwa nini watoto wa ART wana uwezekano mkubwa wa kubeba aina za de novo zisizo-synonymous na rRNA kuliko wenzao wa SC.
     <table-wrap id="Tab5">
      <label>
       Jedwali 5
      </label>
      <caption xml:lang="en">
       <p>
        Uchambuzi wa mifano ya mstari wa jumla na usambazaji wa Poisson kwenye tofauti za de novo katika jozi za mama na mtoto na oocytes
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th/>
         <th>
          <p>
           (B)
          </p>
         </th>
         <th>
          <p>
           95% Wald C.I.
          </p>
         </th>
         <th>
          <p>
           Umuhimu
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            Jumla ya idadi ya
           </bold>
           <bold>
            tofaouti za de novo
           </bold>
           <bold>
            katika jozi za mama na mtoto na oocytes (
           </bold>
           <bold>
            <italic>
             N
            </italic>
           </bold>
           =
           <bold>
            170)
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.037
          </p>
         </td>
         <td>
          <p>
           0.024–0.050
          </p>
         </td>
         <td>
          <p>
           &lt;0.001
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            rRNA
           </bold>
           <bold>
            tofaouti za de novo
           </bold>
           <bold>
            katika jozi za mama na mtoto na oocytes (
           </bold>
           <bold>
            <italic>
             N
            </italic>
           </bold>
           =
           <bold>
            170)
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.054
          </p>
         </td>
         <td>
          <p>
           0.10–0.097
          </p>
         </td>
         <td>
          <p>
           0.015
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            Jumla ya idadi ya
           </bold>
           <bold>
            tofaouti za de novo
           </bold>
           <bold>
            katika oocytes (
           </bold>
           <bold>
            <italic>
             N
            </italic>
           </bold>
           =
           <bold>
            113)
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.079
          </p>
         </td>
         <td>
          <p>
           0.031–0.127
          </p>
         </td>
         <td>
          <p>
           0.001
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Oocytes zilizopatikana
          </p>
         </td>
         <td>
          <p>
           0.017
          </p>
         </td>
         <td>
          <p>
           −0.004–0.037
          </p>
         </td>
         <td>
          <p>
           0.110
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            Jumla ya idadi ya
           </bold>
           <bold>
            tofaouti zisizo za kisanisi na rRNA za de novo
           </bold>
           <bold>
            katika oocytes (
           </bold>
           <bold>
            <italic>
             N
            </italic>
           </bold>
           =
           <bold>
            113)
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.033
          </p>
         </td>
         <td>
          <p>
           −0.003–0.068
          </p>
         </td>
         <td>
          <p>
           0.074
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Oocytes zilizopatikana
          </p>
         </td>
         <td>
          <p>
           0.021
          </p>
         </td>
         <td>
          <p>
           0.006–0.036
          </p>
         </td>
         <td>
          <p>
           0.007
          </p>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
    </p>
   </sec>
  </sec>
  <sec id="Sec7" sec-type="discussion">
   <title>
    Majadiliano
   </title>
   <p id="Par21">
    Utafiti huu unatambua, kwa mara ya kwanza, tofauti za kijenetiki kati ya watoto wa ART na SC zinazohusiana na uzito wao wa kuzaliwa. Tuligundua kuwa mtDNA ya watoto wa ART mara nyingi inaonyesha aina katika maeneo ya msimbo wa protini na rRNA, na kwamba mara nyingi hubeba aina za de novo zisizo-synonymous kuliko wenzao waliozaliwa kwa hiari. Kwa kutumia mifano ya uchambuzi wa regression na discriminant, tuligundua kuwa aina hizi zisizo-synonymous na rRNA zinahusiana na nafasi kubwa ya kuzaliwa chini ya asilimia ya 25 ya uzito wa kuzaliwa katika makundi yote ya ART na SC, lakini kwa uhusiano mkubwa zaidi katika kundi la mwisho. Kwa watoto wa ART, njia ya utamaduni ambayo walifichuliwa nayo wakati wa utamaduni wa kiinitete cha in vitro kabla ya kuhamishwa ilionekana kuwa sababu muhimu ya kuchanganya, hasa katika vyombo vya utamaduni vya zamani ambavyo sasa vimepitwa na wakati. Hatimaye, tuligundua kuwa kuzeeka kwa mama na, kwa watu wa ART, ukubwa wa kundi la mayai yaliyopatikana wakati wa OS, vilikuwa sababu kuu zinazohusiana na tukio la aina za de novo kwa watoto na mayai.
   </p>
   <p id="Par22">
    Mbinu halisi za uhusiano kati ya aina za mtDNA na uzito wa kuzaliwa zinapaswa kufafanuliwa, lakini athari za mabadiliko ya mtDNA kwenye afya na magonjwa zimeandikwa vizuri
    <sup>
     <xref ref-type="bibr" rid="CR62">
      62
     </xref>
     ,
     <xref ref-type="bibr" rid="CR74">
      74
     </xref>
     ,
     <xref ref-type="bibr" rid="CR75">
      75
     </xref>
    </sup>
    . Aina za mtDNA zinazohusiana na magonjwa ya kurithi zinahusishwa na uzito wa chini wa kuzaliwa, unene na upinzani wa insulini, na haplogrupu za mitochondrial zimehusishwa na usawa wa chini wa bioenergetic, utasa na unene
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
     ,
     <xref ref-type="bibr" rid="CR41">
      41
     </xref>
     ,
     <xref ref-type="bibr" rid="CR42">
      42
     </xref>
     <xref ref-type="bibr" rid="CR76">
      76
     </xref>
     <xref ref-type="bibr" rid="CR77">
      77
     </xref>
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR50">
      50
     </xref>
    </sup>
    . Idadi ya aina za homoplasmic na heteroplasmic zimeripotiwa kuhusishwa na muundo wa mwili, ingawa hatukuweza kurudia matokeo haya katika utafiti wetu
    <sup>
     <xref ref-type="bibr" rid="CR43">
      43
     </xref>
     ,
     <xref ref-type="bibr" rid="CR44">
      44
     </xref>
     ,
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR46">
      46
     </xref>
     ,
     <xref ref-type="bibr" rid="CR47">
      47
     </xref>
     ,
     <xref ref-type="bibr" rid="CR48">
      48
     </xref>
     ,
     <xref ref-type="bibr" rid="CR49">
      49
     </xref>
    </sup>
    . Kinyume chake, haplogrupu T inayohusishwa na unene, ilikuwa chini ya uwakilishi katika watu wenye uzito wa chini wa kuzaliwa, na ingawa umuhimu wa takwimu ulipotea baada ya kurekebisha kwa majaribio mengi, matokeo haya yanaunga mkono jukumu la haplogrupu T katika kudhibiti uzito wa mwili. Katika utafiti wetu, tunapata uhusiano wa uzito wa kuzaliwa na uwepo wa aina za heteroplasmic zisizo-synonymous na rRNA zenye mzigo mdogo na uwezo wa pathogenic usiojulikana, kwani hazijahusishwa na magonjwa. Watu wenye afya wanajulikana kubeba aina za heteroplasmic, nyingi ambazo hazizingatiwi kuwa zinazosababisha magonjwa
    <sup>
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR50">
      50
     </xref>
     <xref ref-type="bibr" rid="CR78">
      78
     </xref>
    </sup>
    . Hata hivyo, aina hizi za heteroplasmic zinaweza kuwa chanzo cha tofauti katika hali ya afya na maendeleo ya kuzeeka
    <sup>
     <xref ref-type="bibr" rid="CR75">
      75
     </xref>
    </sup>
    . Kwa mfano, aina zinazobadilisha asidi ya amino au mabadiliko katika mashine ya unakili zinaweza kupunguza ufanisi wa fosforasi ya oksidi na kuongeza uzalishaji wa spishi za oksijeni tendaji
    <sup>
     <xref ref-type="bibr" rid="CR79">
      79
     </xref>
    </sup>
    . Aina za heteroplasmic zimeandikwa vizuri kucheza jukumu muhimu katika kuzeeka, magonjwa ya neurodegenerative na saratani, na mchanganyiko wa aina tofauti zisizo za pathogenic katika mizigo ya chini ya heteroplasmic, kama ilivyopatikana katika utafiti huu, zimeonyeshwa kuwa na athari mbaya ya pamoja kwenye kazi ya mitochondrial
    <sup>
     <xref ref-type="bibr" rid="CR80">
      80
     </xref>
     ,
     <xref ref-type="bibr" rid="CR81">
      81
     </xref>
     ,
     <xref ref-type="bibr" rid="CR82">
      82
     </xref>
     <xref ref-type="bibr" rid="CR83">
      83
     </xref>
     <xref ref-type="bibr" rid="CR84">
      84
     </xref>
    </sup>
    .
   </p>
   <p id="Par23">
    Utafiti wa kundi la jozi za mama na mtoto ulionyesha kuwa tofauti kati ya watu wa ART na SC zilitokana hasa na ongezeko la aina za protini zinazorithiwa kutoka kwa mama na rRNA, pamoja na aina mpya za protini zisizo za kinasaba katika watu wa ART. Tulidhani kuwa OS inaweza kuwa na jukumu katika ongezeko hili la aina mpya, lakini mwanzoni hatukupata tofauti wakati wa kulinganisha moja kwa moja aina za mtDNA katika oocytes za mzunguko wa asili na OS. Kinyume chake, tuligundua kuwa kuzeeka kwa mama kulihusiana vyema na idadi ya aina mpya zilizopatikana katika kizazi kijacho na kwamba ukubwa wa kundi la oocytes zilizopatikana baada ya OS ulilingana vyema na idadi ya aina zisizo za kinasaba na rRNA katika oocyte. Uhusiano tunaopata kati ya umri wa mama na idadi ya aina mpya za mtDNA katika watoto na oocytes unalingana kabisa na tafiti zingine zilizofanywa kwenye jozi za mama na mtoto na kwenye oocytes za panya na nyani, ambapo uhusiano wazi kati ya umri wa mama na mzigo wa mabadiliko ya mtDNA umetambuliwa. Kwa kuzingatia athari kubwa ya umri wa mama kwenye uzito wa kuzaliwa ambayo sisi na wengine tumetambua, inaonekana inawezekana kwamba ongezeko la aina mpya za mtDNA katika oocytes inaweza kuwa mojawapo ya mifumo ambayo umri wa mama ulioendelea husababisha watoto wenye uzito wa chini wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR85">
      85
     </xref>
     ,
     <xref ref-type="bibr" rid="CR86">
      86
     </xref>
     <xref ref-type="bibr" rid="CR87">
      87
     </xref>
     ,
     <xref ref-type="bibr" rid="CR88">
      88
     </xref>
     <xref ref-type="bibr" rid="CR89">
      89
     </xref>
     ,
     <xref ref-type="bibr" rid="CR90">
      90
     </xref>
     ,
     <xref ref-type="bibr" rid="CR91">
      91
     </xref>
    </sup>
    .
   </p>
   <p id="Par24">
    Kwa watoto wa ART, kando na kuzeeka kwa mama, ukubwa wa kundi la oocyte unahusishwa na ongezeko la aina zisizo za kinasaba na rRNA, uhusiano ambao, kwa ufahamu wetu, haujaripotiwa hapo awali. Ufafanuzi unaowezekana wa uchunguzi huu ni kwamba utaratibu wa OS unafuta ushindani wa FSH kati ya mifumo tofauti ya follicle-oocyte inayozindua kukomaa katika mzunguko wa hedhi. Ukosefu huu wa ushindani unaweza kuruhusu ovulation ya oocytes zinazobeba aina za mtDNA zenye madhara, kama vile mabadiliko yasiyo ya kinasaba na katika maeneo ya rRNA, ambayo vinginevyo hushindana na oocyte kuu yenye nguvu zaidi katika mzunguko wa hedhi wa asili
    <sup>
     <xref ref-type="bibr" rid="CR86">
      86
     </xref>
     ,
     <xref ref-type="bibr" rid="CR92">
      92
     </xref>
     ,
     <xref ref-type="bibr" rid="CR93">
      93
     </xref>
    </sup>
    . Tafiti chache zimechunguza uhusiano kati ya OS na uzito wa kuzaliwa, na matokeo yanayokinzana. Mzunguko wa asili wa ART, bila OS, umepatikana kuhusishwa na uzito wa juu wa kuzaliwa kuliko mizunguko yenye OS na Mak et al., lakini si na Sunkara et al.
    <sup>
     <xref ref-type="bibr" rid="CR94">
      94
     </xref>
     <xref ref-type="bibr" rid="CR95">
      95
     </xref>
    </sup>
    . Vivyo hivyo, idadi ya oocytes zilizopatikana imepatikana kuhusishwa na uzito wa chini wa kuzaliwa katika baadhi ya makundi lakini si katika mengine
    <sup>
     <xref ref-type="bibr" rid="CR96">
      96
     </xref>
     <xref ref-type="bibr" rid="CR97">
      97
     </xref>
    </sup>
    . Sababu za tofauti hizi bado hazijafafanuliwa na zinaweza kuwa, angalau kwa sehemu, kutokana na athari kubwa ya vyombo vya utamaduni kwenye maendeleo ya kiinitete na uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR25">
      25
     </xref>
     ,
     <xref ref-type="bibr" rid="CR26">
      26
     </xref>
     ,
     <xref ref-type="bibr" rid="CR27">
      27
     </xref>
     ,
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
     ,
     <xref ref-type="bibr" rid="CR34">
      34
     </xref>
     ,
     <xref ref-type="bibr" rid="CR70">
      70
     </xref>
     ,
     <xref ref-type="bibr" rid="CR98">
      98
     </xref>
    </sup>
    .
   </p>
   <p id="Par25">
    Mwishowe, ni muhimu kuzingatia mapungufu ya utafiti huu. Kwanza, tunaripoti juu ya makundi mawili ya sampuli, zilizokusanywa katika vituo viwili tofauti, ambazo, zinapochambuliwa kando, hazifikii umuhimu wa takwimu kwa matokeo tunayoripoti. Pili, katika kundi hili la utafiti, hakuna tofauti katika uzito wa kuzaliwa kati ya watu wa ART na SC. Inawezekana kwamba tofauti katika jenotipu ya mtDNA kati ya watu wa ART na SC (Fig.
    <xref ref-type="fig" rid="Fig1">
     1
    </xref>
    ) zingekuwa dhahiri zaidi ikiwa uzito wa kuzaliwa katika makundi haya mawili ungekuwa tofauti kwa kiasi kikubwa. Sababu inayoweza kuathiri kipengele hiki ni kwamba watu wa ART walikuwa wamewekwa wazi kwa vyombo vitatu tofauti vya utamaduni, ambavyo wazi vina athari muhimu na tofauti kwenye uzito wa kuzaliwa. Tatu, uhusiano tunaopata kati ya haplogrupu na uzito wa kuzaliwa huenda haujatosha na unapaswa kuchukuliwa kwa tahadhari, kwani hazihifadhi umuhimu wa takwimu katika mifano yote tuliyojaribu. Zaidi ya hayo, wakati mfano wa kutofautisha asilimia ya 10 ya uzito wa kuzaliwa ni thabiti, mfano wa asilimia ya 25 ya uzito wa kuzaliwa ni wa umuhimu wa takwimu tu, na utahitaji marekebisho zaidi na uboreshaji. Nne, aina tunazoripoti kuhusishwa na uzito wa kuzaliwa hazina athari ya kuthibitishwa ya ugonjwa zaidi ya kile ambacho mifano ya in silico inaweza kutoa, na utafiti zaidi utahitajika kuonyesha uhusiano wa molekuli. Mwishowe, ni muhimu kuzingatia kwamba wakati wa kuchambua tishu moja tu kwa kila mtu, haiwezi kutengwa kwamba aina za heteroplasmic zilizotambuliwa ni maalum kwa tishu, katika hali ambayo zilikuwa na uwezo mdogo wa kuathiri uzito wa kuzaliwa wa mtu binafsi. Kwa ujumla, tafiti za kurudia zijazo kwenye makundi makubwa zitakuwa muhimu kuthibitisha matokeo yetu na zitaruhusu uboreshaji wa mifano ya utabiri wa uzito wa kuzaliwa.
   </p>
   <p id="Par26">
    Kwa muhtasari, utafiti wetu umebaini uhusiano kati ya uwepo wa aina za mtDNA zisizo za kinasaba katika maeneo ya protini na loci za rRNA na uzito wa chini wa kuzaliwa, ambazo ni za kawaida zaidi kwa watoto kutoka kwa mama wazee na ambao wamezaliwa baada ya matibabu ya ART. Tunapendekeza kwamba aina hizi zinaweza kusababisha dysfunction ya mitochondrial ya wastani lakini bado ya kutosha kusababisha asilimia ya chini ya uzito wa kuzaliwa, ikitoa ushahidi wa kwanza wa sababu za kijenetiki za mitochondrial ambazo zinaweza kuelezea tofauti zilizozingatiwa kati ya watu wa ART na SC. Matokeo ya muda mrefu ya kiafya ya mabadiliko haya bado yanahitaji kusomwa ili kubaini jinsi matokeo haya yatakavyoathiri mazoezi ya kliniki na ushauri wa wagonjwa katika siku zijazo.
   </p>
  </sec>
  <sec id="Sec8" sec-type="methods">
   <title>
    Mbinu
   </title>
   <p id="Par27">
    Kwa sehemu zote za utafiti huu, muundo na uendeshaji ulifuata kanuni zote zinazohusika kuhusu matumizi ya washiriki wa utafiti wa binadamu, na zote ziliidhinishwa na kamati ya maadili ya ndani ya UZ Brussel na bodi ya mapitio ya maadili ya Kituo cha Matibabu cha Chuo Kikuu cha Maastricht. Watu wote walitoa idhini iliyoandikwa na iliyosainiwa. Washiriki walikubali kuchapishwa kwa vigezo vya kliniki kwa njia isiyojulikana. Utafiti ulifanywa kwa mujibu wa vigezo vilivyowekwa na Azimio la Helsinki.
   </p>
   <sec id="Sec9">
    <title>
     Uajiri na nyenzo za wafadhili
    </title>
    <p id="Par28">
     Washiriki walikusanywa katika Universitair Ziekenhuis Brussel (UZ Brussel, Ubelgiji) na katika Maastricht University Medical Centre (MUMC, Uholanzi). Washiriki wote walitoa idhini ya kufahamishwa na hawakupokea fidia isipokuwa ilivyoelezwa tofauti. Watoto wote wa ART walizaliwa kutoka kwa uhamisho wa kiinitete safi katika hatua ya cleavage, maelezo juu ya matumizi ya sindano ya ndani ya cytoplasmic ya manii (ICSI) au mbolea ya vitro inajulikana kwa mizunguko 150 tu kati ya 270 ya ART. Taarifa hii haikujumuishwa katika uchambuzi kwa sababu ICSI imeonekana kutoongeza hatari ya matokeo mabaya ya uzazi
     <sup>
      <xref ref-type="bibr" rid="CR99">
       99
      </xref>
     </sup>
     . Sampuli za DNA zilizotolewa kutoka kwa damu ya watoto wachanga zilikuwa vifaa vya ziada vilivyokusanywa katika UZ Brussel kwa ajili ya utafiti ulioundwa ili kujaribu kama DNA ya mitochondria ya baba inaweza kupatikana kwa watu waliozaliwa baada ya ISCI
     <sup>
      <xref ref-type="bibr" rid="CR100">
       100
      </xref>
     </sup>
     . Wazazi walitoa idhini ya kufahamishwa. Kamati ya maadili ilitoa ruhusa ya kutumia sampuli za DNA zilizohifadhiwa kwa ajili ya utafiti huu, lakini si vigezo vya kliniki vilivyohusishwa. Sampuli za miaka 9 zilikusanywa katika MUMC, kama sehemu ya utafiti wa ufuatiliaji juu ya utafiti wa kikundi cha uchunguzi wa matarajio
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     . Wazazi walikaribiwa baada ya siku ya tisa ya kuzaliwa kwa mtoto wao kushiriki katika utafiti huu. Kamati ya maadili ya eneo hilo iliidhinisha utafiti na wazazi wote wa watoto wote walitoa idhini ya maandishi. DNA ilitolewa kutoka kwa sampuli za mate. Sampuli za DNA za plasenta zilikusanywa kwa ajili ya utafiti ulioongozwa na MUMC
     <sup>
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
      ,
      <xref ref-type="bibr" rid="CR70">
       70
      </xref>
     </sup>
     . Idhini ya maadili iliombwa lakini iliondolewa, kwa mujibu wa sheria ya Uholanzi, tishu za plasenta za ziada zinaweza kutumika kwa utafiti baada ya idhini ya mgonjwa, bila ruhusa zaidi ya kamati ya maadili kwa kuwa hakuna hatua zilizohitajika ili kupata sampuli. Biopsi za plasenta zilipatikana katika kliniki sita za IVF nchini Uholanzi (Amsterdam UMC, eneo la AMC huko Amsterdam, Hospitali ya Catharina huko Eindhoven, Hospitali ya St. Elisabeth huko Tilburg, Maastricht University Medical Center huko Maastricht na University Medical Center Groningen huko Groningen) na kliniki tano za IVF zilizounganishwa na hospitali hizi, wagonjwa wote walitia saini idhini ya kufahamishwa
     <sup>
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
     </sup>
     . Maelezo juu ya ukusanyaji wa sampuli na uchimbaji yanaweza kupatikana katika kazi iliyochapishwa awali
     <sup>
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
     </sup>
     . Watu wa ART wa miaka 18, sampuli zilikusanywa kama sehemu ya mradi mkubwa juu ya afya ya cardio-metabolic na uzazi wa wanawake na wanaume vijana waliozaliwa baada ya ICSI uliofanywa katika UZ Brussel
     <sup>
      <xref ref-type="bibr" rid="CR101">
       101
      </xref>
      ,
      <xref ref-type="bibr" rid="CR102">
       102
      </xref>
     </sup>
     . Watu hawa ni sehemu ya kikundi ambacho kimefuatiliwa kwa matarajio tangu kuzaliwa. Wazazi wote wa watoto wa ICSI wanaostahiki katika hifadhidata yetu walitumwa barua inayoelezea asili na mpangilio wa utafiti. Muda mfupi baadaye, wazazi hawa walifikiwa kwa simu ili kuchunguza utayari wao na wa watoto wao kushiriki. Baada ya idhini ya wazazi kupatikana, vijana walikaribiwa moja kwa moja na kualikwa kushiriki. Washiriki wote walitia saini idhini ya kufahamishwa na walipokea motisha kwa njia ya vocha ya zawadi. DNA ilitolewa kutoka kwa damu ya pembeni. Kamati ya maadili ya eneo la UZ Brussel iliidhinisha utafiti huu. Watu wa SC wa miaka 18 walikusanywa wanafunzi wa mwaka wa kwanza katika chuo cha Vrije Universiteit Brussel. Walikaribiwa chuoni, ambapo walipokea kijitabu cha habari juu ya utafiti, fomu ya idhini ya kufahamishwa na vifaa muhimu vya kutoa swabu ya mdomo. Wajitolea waliojiandikisha katika utafiti walitia saini idhini ya kufahamishwa kabla ya kutoa sampuli. Utafiti huu uliidhinishwa na kamati ya maadili ya eneo la UZ Brussel.
    </p>
    <p id="Par29">
     Kwa ajili ya utafiti wa oocytes, wanawake ishirini na tisa vijana walitoa oocytes katika hadi mizunguko mitatu ya hedhi ya asili na baada ya mzunguko mmoja wa OS. Wafadhili wote walikusanywa katika Kituo cha Tiba ya Uzazi cha UZ Brussel, kama sehemu ya mpango wa kawaida wa utoaji wa oocyte, ambapo pia taratibu zote za matibabu zilifanyika. Wafadhili wote walitoa idhini ya kufahamishwa kwa taratibu zote za matibabu na kwa matumizi ya oocytes zao kwa utafiti, na walipokea fidia ya kifedha. Kamati ya maadili ya eneo la UZ Brussel iliidhinisha sehemu zote za utafiti huu. Vigezo vya kuingizwa kwa ajili ya uandikishaji vilikuwa: miaka 19-35, afya njema na na index ya uzito wa mwili wa 18-32. Vigezo vya kutengwa vilikuwa: aina yoyote ya hali ya matibabu au ya kijenetiki inayoweza kuathiri afya ya oocytes, viwango vya endometriosis vya American Fertility Society (AFS) III-IV, matatizo ya ovulation yanayohusiana na makundi ya Shirika la Afya Duniani (WHO) 1-6, index ya uzito wa mwili ya &lt;18 au &gt;32, matumizi ya dawa zinazoweza kuathiri uwezo wa oocyte na matatizo ya akili. Wafadhili walipitia aina mbili za mizunguko ya utoaji: hadi mizunguko mitatu ya asili na mzunguko mmoja baada ya OS (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      25
     </xref>
     ). Wakati wa utoaji wa oocyte wa mzunguko wa asili, sampuli ya damu ilichukuliwa siku ya 2 ya awamu ya follicular ili kutathmini vigezo kadhaa: estradiol ya seramu, progesterone, homoni ya luteinizing, homoni ya kuchochea follicle (FSH), na viwango vya gonadotrophin ya chorionic ya binadamu (hCG). Siku ya 10, sampuli ya damu ilichukuliwa tena ili kuangalia vigezo sawa isipokuwa hCG pamoja na ultrasound ya uke ili kutathmini maendeleo ya follicular. Ikiwa haitoshi, sampuli za damu za ziada na ultrasound zilichukuliwa. Utoaji wa oocyte ulifanyika saa 32 baada ya utawala wa 5000 IU hCG ya nje. Mzunguko wa OS ulianza siku ya kwanza ya hedhi kufuatia mzunguko wa asili. Kuanzia siku ya 2 ya mzunguko, itifaki ya mpinzani wa homoni ya kutolewa gonadotrophin (GnRH) ilitumika, ikitumia FSH ya recombinant ikiwa uchambuzi wa homoni ulikuwa ndani ya mipaka ya kawaida siku ya 2. Kipimo cha kuanzia cha FSH ya recombinant kilitofautiana kati ya 150-300 IU kwa siku. Siku ya 6 ya kuchochea, mpinzani wa GnRH (Ganirelix; Orgalutran®; MSD, Oss, Uholanzi) na kipimo cha 0.25 mg kwa siku kilitolewa. Ukamilishaji wa mwisho wa oocyte ulifikiwa kwa utawala wa agonist ya GnRH (Gonapeptyol®, Ferring Pharmaceuticals, St-Prex, Uswisi) na kipimo cha 0.2 ml wakati angalau follicles 3 zilifikia kipenyo cha wastani cha 17-20 mm. Utoaji wa oocyte ulifanyika kulingana na taratibu za kawaida, saa 36 baada ya kichocheo.
    </p>
   </sec>
   <sec id="Sec10">
    <title>
     Uondoaji wa DNA na itifaki ya PCR ya masafa marefu kwa ajili ya utajiri wa mtDNA
    </title>
    <p id="Par30">
     DNA ilitolewa kutoka kwa damu ya pembeni, plasenta, mate na sampuli za swabu ya mdomo, na kutengwa kutoka kwa oocytes moja kama ilivyoelezwa hapo awali na kikundi chetu
     <sup>
      <xref ref-type="bibr" rid="CR103">
       103
      </xref>
      ,
      <xref ref-type="bibr" rid="CR104">
       104
      </xref>
     </sup>
     . mtDNA iliboreshwa kwa kutumia PCR ya muda mrefu kwa kutumia seti mbili za primer kufunika mtDNA yote katika sampuli za DNA nyingi. Kwa oocytes moja, seti ya kwanza ya primer tu ilitumika. Mfuatano wa seti ya kwanza ya primer (5042f-1424r) ulikuwa 5′-AGC AGT TCT ACC GTA CAA CC-3′ (mbele) na 5′-ATC CAC CTT CGA CCC TTA AG-3′ (nyuma) ikizalisha amplicons ya 12.9 Kb. Mfuatano wa seti ya pili ya primer (528f-5789r) ulikuwa 5′-TGC TAA CCC CAT ACC CCG AAC C-3′ (mbele) na 5′-AAG AAG CAG CTT CAA ACC TGC C-3′ (nyuma) ikizalisha amplicons ya 5.3 Kb. Seti zote mbili za primer zilinunuliwa kutoka Integrated DNA Technologies, zilipunguzwa hadi 10 µmol na kuhifadhiwa kwa -20 °C. Mchanganyiko mkuu wa PCR ya muda mrefu ulitayarishwa kama ifuatavyo: 10 µL ya 5x LongAmp buffer (LongAmp Taq DNA Polymerase kit M0323L, New England Biolabs, iliyohifadhiwa kwa -20 °C), 7.5 µL dNTPs (dNTP set, IllustraTM, iliyopunguzwa hadi 2 mM na kuhifadhiwa kwa -20 °C), 2 µL ya primer za mbele na nyuma (10 µM), 2 µL ya Taq Polymerase LongAmp (vitengo 5) na 50 ng ya DNA iliyopunguzwa (suluhisho la kazi: 10 ng/µL) katika jumla ya 50 µL. Katika kesi ya oocytes, PCR ya muda mrefu ya seli moja ilitumika. Hapa, seti ya kwanza ya primer tu ilitumika na 2.5 µL ya Tricine (Sigma-Aldrich T9784, iliyopunguzwa hadi 200 nM na kuhifadhiwa kwa 4 °C) iliongezwa ili kubuffer lysis buffer ya alkali (200 mM NaOH na 50 mM DTT) iliyotumika katika ukusanyaji wa oocyte. Mchanganyiko mkuu uliongezwa moja kwa moja kwenye sampuli. Uthibitisho wa mafanikio ya PCR ulithibitishwa kwa kuendesha gel-electrophoresis. Umaalumu wa seti za primer kwa genome ya mitochondria ulidhibitiwa kwa kuzidisha DNA ya seli za RhoZero, ambazo hazina DNA ya mitochondria. Itifaki za kina zaidi za PCR ya muda mrefu na uthibitishaji wa kina wa mbinu zilichapishwa hapo awali
     <sup>
      <xref ref-type="bibr" rid="CR104">
       104
      </xref>
      ,
      <xref ref-type="bibr" rid="CR105">
       105
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec11">
    <title>
     Maandalizi ya sampuli kwa ajili ya upimaji wa mfuatano na uchambuzi wa data
    </title>
    <p id="Par31">
     Baada ya kuzidisha kwa PCR, sampuli zilifanywa safi kwa kutumia shanga za AMPure na amplicons kutoka seti zote mbili za primer zilipooliwa pamoja katika uwiano wa 0.35/0.65 (35% ya amplicon kutoka seti ya pili ya primer na 65% ya amplicon ya seti ya kwanza ya primer). Kisha, maktaba ilitayarishwa kwa kutumia kit cha KAPA HyperPlus na kusafishwa kwa kutumia shanga za AMPure. Ubora wa maktaba ulikaguliwa kwa kutumia electrophoresis kwenye AATI Fragment Analyzer kwa kutumia kit cha HS NGS Fragment. Kisha, maktaba zilipunguzwa hadi 2 nM katika buffer ya EBT na kupooliwa kabla ya kufuatilia kwenye jukwaa la Illumina. Data mbichi ya kufuatilia inachukuliwa kuwa data ya kibinafsi na Kanuni ya Ulinzi wa Data ya Jumla ya Umoja wa Ulaya (Kanuni (EU) 2016/679) na haiwezi kushirikiwa hadharani. Data inaweza kupatikana kutoka kwa mwandishi anayehusika baada ya ombi la busara na baada ya kusaini Mkataba wa Matumizi ya Data. Ulinganifu na genome ya kumbukumbu (NC_0.12920.1) ulifanywa kwa kutumia BWA-MEM. Faili za bam zilizotengenezwa zilipakiwa kwenye jukwaa la mtandaoni "mtDNA server" ili kubaini haplogroup na kutambua tofauti zingine za homoplasmic na heteroplasmic (
     <ext-link ext-link-type="uri" href="https://mitoverse.i-med.ac.at/">
      https://mitoverse.i-med.ac.at/
     </ext-link>
     ) na MuTect2 ilitumika kugundua kuingizwa na kufutwa kwa ndogo. Tofauti zilizo na mzigo wa heteroplasmic ≥1.5% (yaani zaidi au sawa na 1.5% ya molekuli zote zilizofuatiliwa zilikuwa na tofauti), au ≥2% katika kesi ya oocytes moja, ziliandikwa na mabadiliko ya amino-asidi yanayowezekana yalitambuliwa kwa kutumia MitImpact2
     <sup>
      <xref ref-type="bibr" rid="CR106">
       106
      </xref>
      <xref ref-type="bibr" rid="CR107">
       107
      </xref>
      <xref ref-type="bibr" rid="CR108">
       108
      </xref>
     </sup>
     . Homoplasmies zilifafanuliwa kama tofauti zilizo na mzigo &gt;98.5% (100% minus the detection limit) kwa sampuli za watoto na mama, kwa oocytes hii ilikuwa &gt;98%. Tuliondoa tofauti ambazo ziliitwa katika seti ya maeneo tofauti ambayo yalikuwa na tabia ya kuzalisha makosa ya PCR na kufuatilia, na kusababisha 1037 bp kuondolewa kutoka kwa uchambuzi wa mwisho (Fig.
     <xref ref-type="fig" rid="Fig1">
      1a
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      28
     </xref>
     ). Tofauti zilizotambuliwa katika sampuli zote zilizojumuishwa katika utafiti huu zimeorodheshwa katika faili ya data ya ziada, ikiwa ni pamoja na alama za utabiri wa pathogenicity za tofauti ambazo ni za usimbaji wa protini zisizo za kinasaba au za tRNA. Alama za pathogenicity zilipatikana kupitia uchambuzi wa in silico kwa kutumia MutPred2 kwa tofauti zisizo za kinasaba na MitoTip kwa tofauti za tRNA. Alama za MutPred2 &gt;0.61 na alama za MitoTip &gt;50% zilizingatiwa kuwa zinaweza kuwa na pathogenic. Mbinu hii, ikiwa ni pamoja na PCR, kufuatilia na uchambuzi wa data, ilianzishwa hapo awali katika maabara yetu na kuthibitishwa kwa kina na kizingiti cha chini cha kugundua (kiwango cha heteroplasmic) cha 2% kwa seli moja na 1.5% kwa nyenzo nyingi, kulingana na uchambuzi wa mara nyingi wa sampuli sawa, ikiwa ni pamoja na seli nyingi moja na mchanganyiko wa sampuli za DNA kuiga viwango vingi vya heteroplasmy
     <sup>
      <xref ref-type="bibr" rid="CR71">
       71
      </xref>
      <xref ref-type="bibr" rid="CR109">
       109
      </xref>
      <xref ref-type="bibr" rid="CR105">
       105
      </xref>
      ,
      <xref ref-type="bibr" rid="CR110">
       110
      </xref>
      ,
      <xref ref-type="bibr" rid="CR111">
       111
      </xref>
     </sup>
     . Tofauti zote za DNA ya mitochondria zilizotajwa katika sampuli zote zinatolewa na karatasi hii katika faili ya Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM9">
      6
     </xref>
     .
    </p>
   </sec>
   <sec id="Sec12">
    <title>
     Takwimu
    </title>
    <p id="Par32">
     Uchambuzi wa takwimu ulifanywa kwa kutumia SPSS (IBM). Tofauti za heteroplasmic zilichambuliwa kupitia uchambuzi wa sababu za uchunguzi wa mzunguko wa orthogonally, ambao unatoa utofauti kati ya vigezo katika mfumo wa vigezo vya siri huru (maelezo zaidi yanaweza kupatikana katika faili ya habari ya ziada, katika Fig. ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      29
     </xref>
     na Fig. ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ). Usajili wa binary logistic na uchambuzi wa kutofautisha ulitumika kujenga mifano ya kutabiri athari za vigezo tofauti kwenye asilimia ya uzito wa kuzaliwa. Kwa haya, sampuli zilizo na data iliyokosekana ziliondolewa kutoka kwa uchambuzi. Uchambuzi mwingine wa takwimu ulifanywa kwa kutumia Fisher's exact, Mann–Whitney U na mtihani wa t wa Wanafunzi. Vipimo vyote vya takwimu vilikuwa vya pande mbili na
     <italic>
      p
     </italic>
     -values &lt; 0.05 zilizingatiwa kuwa muhimu. Marekebisho ya majaribio mengi yalifanywa kwa kutumia mbinu ya Bonferroni, na kizingiti kilichorekebishwa cha umuhimu kinaonyeshwa pale inapohusika.
    </p>
   </sec>
   <sec id="Sec13">
    <title>
     Muhtasari wa kuripoti
    </title>
    <p id="Par33">
     Maelezo zaidi juu ya muundo wa utafiti yanapatikana katika
     <xref ref-type="supplementary-material" rid="MOESM10">
      Muhtasari wa Ripoti ya Nature Portfolio
     </xref>
     iliyounganishwa na makala hii.
    </p>
   </sec>
  </sec>
 </body>
 <back>
  <ack>
   <title>
    Shukrani
   </title>
   <p>
    Waandishi wangependa kutoa shukrani zao za dhati kwa wafanyakazi wote wa Kituo cha Tiba ya Uzazi katika UZ Brussel kwa ushirikiano wao katika utafiti huu, na kuwashukuru Hatice Satilmis, Jo Bossuyt na Khadija Rhioui kwa msaada wao katika ukusanyaji wa data kwa ajili ya karatasi hii. Pia tunawashukuru Iain Johnston na Joanna Poulton kwa kusoma kwa makini na michango ya kisayansi yenye thamani kwa kazi yetu. Utafiti huu ulifadhiliwa na Shirika la Utafiti Flanders (FWO, Nambari za Ruzuku 1506617N na 1506717N, kwa C.S.), na Mfuko wa Kisayansi Willy Gepts wa UZ Brussel (Nambari za Ruzuku WFWG14-15, WFWG16-43, WFWG19-19, kwa C.S.), Ruzuku ya Methusalem ya Vrije Universiteit Brussel (kwa K.S.), na na March of Dimes (6-FY13-153 kwa A.P.A.V.M). M.R. na E.C.D.D. ni wanafunzi wa udaktari wanaosaidiwa na FWO, Nambari za Ruzuku 1133622N na 1S73521N, mtawalia.
   </p>
  </ack>
  <sec sec-type="author-contribution">
   <title>
    Mchango wa waandishi
   </title>
   <p>
    J.M., F.B., A.P.A.V.M., M.B., K.St. na F.Z. walikusanya washiriki wa utafiti, waliandaa sampuli na kukusanya vigezo vya kliniki. H.V.D.V., H.T. na C.B. walikusanya wafadhili wa oocyte na walikuwa na jukumu la taratibu za matibabu kwa ajili ya uchukuaji na ukusanyaji wa oocyte. J.M. na F.Z. walifanya maandalizi ya sampuli kwa ajili ya upimaji wa DNA. J.M. na E.C.D.D. walifanya uchambuzi wa bioinformatics wa data ya upimaji. J.M. alikusanya na kutunza seti ya data. M.R. alitengeneza takwimu zote katika maandiko na alichangia katika uchambuzi wa takwimu. K.B. alishauri juu ya mbinu zote za takwimu na alibuni uchambuzi wa sababu kwa tofauti za mitochondrial. S.S. na H.S. walichangia katika tafsiri ya tofauti za mitochondrial na muundo wa jumla wa utafiti. K.Se. alitoa ufadhili kwa ajili ya utafiti huu na alichangia katika muundo wa jumla wa utafiti. J.M. na C.S. walifanya uchambuzi wa takwimu, walitafsiri matokeo na waliandika kwa pamoja maandiko. C.S. alibuni utafiti, alitoa ufadhili na alisimamia utafiti. Waandishi wote walisoma maandiko na walikubali toleo lake la mwisho.
   </p>
  </sec>
  <sec sec-type="peer-review">
   <title>
    Mapitio ya wenzao
   </title>
   <sec id="FPar1">
    <title>
     Taarifa za mapitio ya wenzao
    </title>
    <p id="Par34">
     <italic>
      Nature Communications
     </italic>
     thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.
    </p>
   </sec>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Upatikanaji wa data
   </title>
   <p>
    The raw sequencing data is considered personal data by the General Data Protection Regulation of the European Union (Regulation (EU) 2016/679) and cannot be publicly shared. The data can be obtained from the corresponding author upon request and after signing a Data Use Agreement. All mitochondrial DNA variants called in all samples are provided with this paper in the Supplementary Data
    <xref ref-type="supplementary-material" rid="MOESM9">
     6
    </xref>
    file, as well as the clinical parameters associated to the samples.
    <xref ref-type="sec" rid="Sec15">
     Source data
    </xref>
    are provided with this paper.
   </p>
  </sec>
  <sec sec-type="ethics-statement">
   <sec id="FPar2" sec-type="COI-statement">
    <title>
     Maslahi yanayokinzana
    </title>
    <p id="Par35">
     The authors declare no competing interests.
    </p>
   </sec>
  </sec>
  <ref-list id="Bib1">
   <title>
    Marejeleo
   </title>
   <ref-list>
    <ref id="CR1">
     <label>
      1.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Luke
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The risk of birth defects with conception by ART
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2021
      </year>
      <volume>
       36
      </volume>
      <fpage>
       116
      </fpage>
      <lpage>
       129
      </lpage>
      <pub-id pub-id-type="pmid">
       33251542
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deaa272
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR2">
     <label>
      2.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Qin
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis
      </article-title>
      <source>
       Arch. Gynecol. Obstet.
      </source>
      <year>
       2017
      </year>
      <volume>
       295
      </volume>
      <fpage>
       285
      </fpage>
      <lpage>
       301
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XitVWms7rF
      </pub-id>
      <pub-id pub-id-type="pmid">
       27896474
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00404-016-4250-3
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR3">
     <label>
      3.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Pandey
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Shetty
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Hamilton
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bhattacharya
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Maheshwari
        </surname>
        <given-names>
         A
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2012
      </year>
      <volume>
       18
      </volume>
      <fpage>
       485
      </fpage>
      <lpage>
       503
      </lpage>
      <pub-id pub-id-type="pmid">
       22611174
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dms018
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR4">
     <label>
      4.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Pinborg
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2013
      </year>
      <volume>
       19
      </volume>
      <fpage>
       87
      </fpage>
      <lpage>
       104
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BC3s7js1SktA%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23154145
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dms044
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR5">
     <label>
      5.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Maheshwari
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2018
      </year>
      <volume>
       24
      </volume>
      <fpage>
       35
      </fpage>
      <lpage>
       58
      </lpage>
      <pub-id pub-id-type="pmid">
       29155965
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dmx031
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR6">
     <label>
      6.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Magnusson
        </surname>
        <given-names>
         Å
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The association between high birth weight and long-term outcomes—implications for assisted reproductive technologies: a systematic review and meta-analysis
      </article-title>
      <source>
       Front. Pediatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       9
      </volume>
      <fpage>
       675775
      </fpage>
      <pub-id pub-id-type="pmid">
       34249812
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8260985
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fped.2021.675775
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR7">
     <label>
      7.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sargisian
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cancer in children born after frozen-thawed embryo transfer: a cohort study
      </article-title>
      <source>
       PLoS Med.
      </source>
      <year>
       2022
      </year>
      <volume>
       19
      </volume>
      <fpage>
       e1004078
      </fpage>
      <pub-id pub-id-type="pmid">
       36048761
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9436139
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pmed.1004078
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR8">
     <label>
      8.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Belva
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Are ICSI adolescents at risk for increased adiposity?
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2012
      </year>
      <volume>
       27
      </volume>
      <fpage>
       257
      </fpage>
      <lpage>
       264
      </lpage>
      <pub-id pub-id-type="pmid">
       22081314
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/der375
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR9">
     <label>
      9.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ceelen
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Van Weissenbruch
        </surname>
        <given-names>
         MM
        </given-names>
       </name>
       <name>
        <surname>
         Vermeiden
        </surname>
        <given-names>
         JPW
        </given-names>
       </name>
       <name>
        <surname>
         Van Leeuwen
        </surname>
        <given-names>
         FE
        </given-names>
       </name>
       <name>
        <surname>
         Delemarre-Van De Waal
        </surname>
        <given-names>
         HA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Cardiometabolic differences in children born after in vitro fertilization: follow-up study
      </article-title>
      <source>
       J. Clin. Endocrinol. Metab.
      </source>
      <year>
       2008
      </year>
      <volume>
       93
      </volume>
      <fpage>
       1682
      </fpage>
      <lpage>
       1688
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXlvFWgs78%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       18285409
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1210/jc.2007-2432
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR10">
     <label>
      10.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ceelen
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         van Weissenbruch
        </surname>
        <given-names>
         MM
        </given-names>
       </name>
       <name>
        <surname>
         Vermeiden
        </surname>
        <given-names>
         JPW
        </given-names>
       </name>
       <name>
        <surname>
         van Leeuwen
        </surname>
        <given-names>
         FE
        </given-names>
       </name>
       <name>
        <surname>
         Delemarre-van de Waal
        </surname>
        <given-names>
         HA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Pubertal development in children and adolescents born after IVF and spontaneous conception
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2008
      </year>
      <volume>
       23
      </volume>
      <fpage>
       2791
      </fpage>
      <lpage>
       2798
      </lpage>
      <pub-id pub-id-type="pmid">
       18689849
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/den309
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR11">
     <label>
      11.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cui
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Increased risk of metabolic dysfunction in children conceived by assisted reproductive technology
      </article-title>
      <source>
       Diabetologia
      </source>
      <year>
       2020
      </year>
      <volume>
       63
      </volume>
      <fpage>
       2150
      </fpage>
      <lpage>
       2157
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXhsFKltLzM
      </pub-id>
      <pub-id pub-id-type="pmid">
       32757153
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00125-020-05241-1
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR12">
     <label>
      12.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Guo
        </surname>
        <given-names>
         X-Y
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cardiovascular and metabolic profiles of offspring conceived by assisted reproductive technologies: a systematic review and meta-analysis
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2017
      </year>
      <volume>
       107
      </volume>
      <fpage>
       622
      </fpage>
      <lpage>
       631.e5
      </lpage>
      <pub-id pub-id-type="pmid">
       28104241
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2016.12.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR13">
     <label>
      13.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Meister
        </surname>
        <given-names>
         TA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Association of assisted reproductive technologies with arterial hypertension during adolescence
      </article-title>
      <source>
       J. Am. Coll. Cardiol.
      </source>
      <year>
       2018
      </year>
      <volume>
       72
      </volume>
      <fpage>
       1267
      </fpage>
      <lpage>
       1274
      </lpage>
      <pub-id pub-id-type="pmid">
       30190005
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.jacc.2018.06.060
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR14">
     <label>
      14.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Valenzuela‐Alcaraz
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Postnatal persistence of fetal cardiovascular remodelling associated with assisted reproductive technologies: a cohort study
      </article-title>
      <source>
       BJOG Int. J. Obstet. Gynaecol.
      </source>
      <year>
       2019
      </year>
      <volume>
       126
      </volume>
      <fpage>
       291
      </fpage>
      <lpage>
       298
      </lpage>
      <pub-id pub-id-type="doi">
       10.1111/1471-0528.15246
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR15">
     <label>
      15.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gluckman
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Hanson
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Phil
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <name>
        <surname>
         Cooper
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Thornburg
        </surname>
        <given-names>
         K
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Disease, effect of in utero and early-life conditions on adult health and disease
      </article-title>
      <source>
       N. Engl. J. Med.
      </source>
      <year>
       2014
      </year>
      <volume>
       359
      </volume>
      <fpage>
       61
      </fpage>
      <lpage>
       73
      </lpage>
      <pub-id pub-id-type="doi">
       10.1056/NEJMra0708473
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR16">
     <label>
      16.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Middelburg
        </surname>
        <given-names>
         KJ
        </given-names>
       </name>
       <name>
        <surname>
         Haadsma
        </surname>
        <given-names>
         ML
        </given-names>
       </name>
       <name>
        <surname>
         Heineman
        </surname>
        <given-names>
         MJ
        </given-names>
       </name>
       <name>
        <surname>
         Bos
        </surname>
        <given-names>
         AF
        </given-names>
       </name>
       <name>
        <surname>
         Hadders-Algra
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Ovarian hyperstimulation and the in vitro fertilization procedure do not influence early neuromotor development; a history of subfertility does
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2010
      </year>
      <volume>
       93
      </volume>
      <fpage>
       544
      </fpage>
      <lpage>
       553
      </lpage>
      <pub-id pub-id-type="pmid">
       19361794
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2009.03.008
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR17">
     <label>
      17.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Romundstad
        </surname>
        <given-names>
         LB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2008
      </year>
      <volume>
       372
      </volume>
      <fpage>
       737
      </fpage>
      <lpage>
       743
      </lpage>
      <pub-id pub-id-type="pmid">
       18674812
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(08)61041-7
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR18">
     <label>
      18.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunkara
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         Antonisamy
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Redla
        </surname>
        <given-names>
         AC
        </given-names>
       </name>
       <name>
        <surname>
         Kamath
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Female causes of infertility are associated with higher risk of preterm birth and low birth weight: analysis of 117 401 singleton live births following IVF
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2021
      </year>
      <volume>
       36
      </volume>
      <fpage>
       676
      </fpage>
      <lpage>
       682
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3MXitValsb%2FK
      </pub-id>
      <pub-id pub-id-type="pmid">
       33367914
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deaa283
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR19">
     <label>
      19.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cooper
        </surname>
        <given-names>
         AR
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Smaller fetal size in singletons after infertility therapies: the influence of technology and the underlying infertility
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2011
      </year>
      <volume>
       96
      </volume>
      <fpage>
       1100
      </fpage>
      <lpage>
       1106
      </lpage>
      <pub-id pub-id-type="pmid">
       21944928
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3212582
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2011.08.038
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR20">
     <label>
      20.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Luke
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Gopal
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <name>
        <surname>
         Cabral
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Diop
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Stern
        </surname>
        <given-names>
         JE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Perinatal outcomes of singleton siblings: the effects of changing maternal fertility status
      </article-title>
      <source>
       J. Assist. Reprod. Genet.
      </source>
      <year>
       2016
      </year>
      <volume>
       33
      </volume>
      <fpage>
       1203
      </fpage>
      <lpage>
       1213
      </lpage>
      <pub-id pub-id-type="pmid">
       27318927
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5010815
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10815-016-0757-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR21">
     <label>
      21.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kalra
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         Ratcliffe
        </surname>
        <given-names>
         SJ
        </given-names>
       </name>
       <name>
        <surname>
         Coutifaris
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Molinaro
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Barnhart
        </surname>
        <given-names>
         KT
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Ovarian stimulation and low birth weight in infants conceived through in vitro fertilization
      </article-title>
      <source>
       Obstet. Gynecol.
      </source>
      <year>
       2011
      </year>
      <volume>
       118
      </volume>
      <fpage>
       863
      </fpage>
      <pub-id pub-id-type="pmid">
       21934450
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3178887
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/AOG.0b013e31822be65f
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR22">
     <label>
      22.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kapiteijn
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation?
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2006
      </year>
      <volume>
       21
      </volume>
      <fpage>
       3228
      </fpage>
      <lpage>
       3234
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD28nnsFGgtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       17023490
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/del311
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR23">
     <label>
      23.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Pelinck
        </surname>
        <given-names>
         MJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is the birthweight of singletons born after IVF reduced by ovarian stimulation or by IVF laboratory procedures?
      </article-title>
      <source>
       Reprod. Biomed. Online
      </source>
      <year>
       2010
      </year>
      <volume>
       21
      </volume>
      <fpage>
       245
      </fpage>
      <lpage>
       251
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BC3cfgtVSmsg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       20538525
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.rbmo.2010.04.024
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR24">
     <label>
      24.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zhu
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Chen
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <name>
        <surname>
         Liu
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Qiao
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The protein source in embryo culture media influences birthweight: a comparative study between G1 v5 and G1-PLUS v5
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2014
      </year>
      <volume>
       29
      </volume>
      <fpage>
       1387
      </fpage>
      <lpage>
       1392
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhtVaks7nP
      </pub-id>
      <pub-id pub-id-type="pmid">
       24812314
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu103
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR25">
     <label>
      25.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Dumoulin
        </surname>
        <given-names>
         JC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effect of in vitro culture of human embryos on birthweight of newborns
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2010
      </year>
      <volume>
       25
      </volume>
      <fpage>
       605
      </fpage>
      <lpage>
       612
      </lpage>
      <pub-id pub-id-type="pmid">
       20085915
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dep456
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR26">
     <label>
      26.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kleijkers
        </surname>
        <given-names>
         SHM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Influence of embryo culture medium (G5 and HTF) on pregnancy and perinatal outcome after IVF: a multicenter RCT
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2219
      </fpage>
      <lpage>
       2230
      </lpage>
      <pub-id pub-id-type="pmid">
       27554441
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew156
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR27">
     <label>
      27.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunde
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Time to take human embryo culture seriously
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2174
      </fpage>
      <lpage>
       2182
      </lpage>
      <pub-id pub-id-type="pmid">
       27554442
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew157
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR28">
     <label>
      28.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zandstra
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Van Montfoort
        </surname>
        <given-names>
         APA
        </given-names>
       </name>
       <name>
        <surname>
         Dumoulin
        </surname>
        <given-names>
         JCM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Does the type of culture medium used influence birthweight of children born after IVF?
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2015
      </year>
      <volume>
       30
      </volume>
      <fpage>
       530
      </fpage>
      <lpage>
       542
      </lpage>
      <pub-id pub-id-type="pmid">
       25574031
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu346
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR29">
     <label>
      29.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mani
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Ghosh
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Coutifaris
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Sapienza
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Mainigi
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Epigenetic changes and assisted reproductive technologies
      </article-title>
      <source>
       Epigenetics
      </source>
      <year>
       2020
      </year>
      <volume>
       15
      </volume>
      <fpage>
       12
      </fpage>
      <lpage>
       25
      </lpage>
      <pub-id pub-id-type="pmid">
       31328632
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1080/15592294.2019.1646572
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR30">
     <label>
      30.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         El Hajj
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <name>
        <surname>
         Haaf
        </surname>
        <given-names>
         T
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Epigenetic disturbances in in vitro cultured gametes and embryos: implications for human assisted reproduction
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2013
      </year>
      <volume>
       99
      </volume>
      <fpage>
       632
      </fpage>
      <lpage>
       641
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhvFWmsbs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23357453
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2012.12.044
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR31">
     <label>
      31.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lazaraviciute
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Kauser
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bhattacharya
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Haggarty
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Bhattacharya
        </surname>
        <given-names>
         S
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2014
      </year>
      <volume>
       20
      </volume>
      <fpage>
       840
      </fpage>
      <lpage>
       852
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXkt1ygsbk%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24961233
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dmu033
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR32">
     <label>
      32.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ducreux
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genome-wide analysis of DNA methylation in buccal cells of children conceived through IVF and ICSI
      </article-title>
      <source>
       Genes
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       1912
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XptVKluw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       34946866
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8701402
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/genes12121912
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR33">
     <label>
      33.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Koeck
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       At age 9, the methylome of assisted reproductive technology children that underwent embryo culture in different media is not significantly different on a genome-wide scale
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2022
      </year>
      <volume>
       37
      </volume>
      <fpage>
       2709
      </fpage>
      <lpage>
       2721
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3sXpsF2ltr4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       36206092
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9627755
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deac213
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR34">
     <label>
      34.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mulder
        </surname>
        <given-names>
         CL
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Comparison of DNA methylation patterns of parentally imprinted genes in placenta derived from IVF conceptions in two different culture media
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2020
      </year>
      <volume>
       35
      </volume>
      <fpage>
       516
      </fpage>
      <lpage>
       528
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitVKqt7bO
      </pub-id>
      <pub-id pub-id-type="pmid">
       32222762
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7105329
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deaa004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR35">
     <label>
      35.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Oliver
        </surname>
        <given-names>
         VF
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Defects in imprinting and genome-wide DNA methylation are not common in the in vitro fertilization population
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2012
      </year>
      <volume>
       97
      </volume>
      <fpage>
       147
      </fpage>
      <lpage>
       53.e7
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38Xht12rtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       22112648
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2011.10.027
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR36">
     <label>
      36.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Whitelaw
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Epigenetic status in the offspring of spontaneous and assisted conception
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2014
      </year>
      <volume>
       29
      </volume>
      <fpage>
       1452
      </fpage>
      <lpage>
       1458
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhtVaks7nI
      </pub-id>
      <pub-id pub-id-type="pmid">
       24812310
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu094
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR37">
     <label>
      37.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Esteki
        </surname>
        <given-names>
         MZ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       In vitro fertilization does not increase the incidence of de novo copy number alterations in fetal and placental lineages
      </article-title>
      <source>
       Nat. Med.
      </source>
      <year>
       2019
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1699
      </fpage>
      <lpage>
       1705
      </lpage>
      <pub-id pub-id-type="doi">
       10.1038/s41591-019-0620-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR38">
     <label>
      38.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Luiza
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Early Human Development Premature birth, low birth weight, small for gestational age and chronic non-communicable diseases in adult life: a systematic review with meta-analysis
      </article-title>
      <source>
       Early Hum. Dev.
      </source>
      <year>
       2020
      </year>
      <volume>
       149
      </volume>
      <fpage>
       105154
      </fpage>
      <pub-id pub-id-type="doi">
       10.1016/j.earlhumdev.2020.105154
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR39">
     <label>
      39.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Bhatti
        </surname>
        <given-names>
         JS
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial dysfunction and oxidative stress in metabolic disorders—a step towards mitochondria based therapeutic strategies
      </article-title>
      <source>
       Biochim. Biophys. Acta Mol. Basis Dis.
      </source>
      <year>
       2018
      </year>
      <volume>
       1863
      </volume>
      <fpage>
       1066
      </fpage>
      <lpage>
       1077
      </lpage>
      <pub-id pub-id-type="doi">
       10.1016/j.bbadis.2016.11.010
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR40">
     <label>
      40.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Schaefer
        </surname>
        <given-names>
         AM
        </given-names>
       </name>
       <name>
        <surname>
         Walker
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Turnbull
        </surname>
        <given-names>
         DM
        </given-names>
       </name>
       <name>
        <surname>
         Taylor
        </surname>
        <given-names>
         RW
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Endocrine disorders in mitochondrial disease
      </article-title>
      <source>
       Mol. Cell. Endocrinol.
      </source>
      <year>
       2013
      </year>
      <volume>
       379
      </volume>
      <fpage>
       2
      </fpage>
      <lpage>
       11
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhtVehsLfE
      </pub-id>
      <pub-id pub-id-type="pmid">
       23769710
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3820028
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.mce.2013.06.004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR41">
     <label>
      41.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses
      </article-title>
      <source>
       Pediatrics
      </source>
      <year>
       2008
      </year>
      <volume>
       122
      </volume>
      <fpage>
       1003
      </fpage>
      <lpage>
       1008
      </lpage>
      <pub-id pub-id-type="pmid">
       18977979
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1542/peds.2007-3502
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR42">
     <label>
      42.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         von Kleist-Retzow
        </surname>
        <given-names>
         J-C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Antenatal manifestations of mitochondrial respiratory chain deficiency
      </article-title>
      <source>
       J. Pediatr.
      </source>
      <year>
       2003
      </year>
      <volume>
       143
      </volume>
      <fpage>
       208
      </fpage>
      <lpage>
       212
      </lpage>
      <pub-id pub-id-type="doi">
       10.1067/S0022-3476(03)00130-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR43">
     <label>
      43.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Casteels
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial 16189 variant, thinnnes at birth, and type-2 diabetes
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       1999
      </year>
      <volume>
       353
      </volume>
      <fpage>
       1499
      </fpage>
      <lpage>
       1500
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DyaK1M3kslartQ%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10232327
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(98)05817-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR44">
     <label>
      44.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Casteels
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       1999
      </year>
      <volume>
       353
      </volume>
      <fpage>
       1499
      </fpage>
      <lpage>
       1500
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DyaK1M3kslartQ%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10232327
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(98)05817-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR45">
     <label>
      45.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ebner
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial haplogroup T is associated with obesity in Austrian juveniles and adults
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2015
      </year>
      <volume>
       10
      </volume>
      <fpage>
       e0135622
      </fpage>
      <pub-id pub-id-type="pmid">
       26322975
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4556186
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0135622
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR46">
     <label>
      46.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Flaquer
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial genetic variants identified to be associated with BMI in adults
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2014
      </year>
      <volume>
       9
      </volume>
      <fpage>
       e105116
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014PLoSO...9j5116F
      </pub-id>
      <pub-id pub-id-type="pmid">
       25153900
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4143221
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0105116
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR47">
     <label>
      47.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Knoll
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA variants in obesity
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2014
      </year>
      <volume>
       9
      </volume>
      <fpage>
       e94882
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014PLoSO...994882K
      </pub-id>
      <pub-id pub-id-type="pmid">
       24788344
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4008486
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0094882
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR48">
     <label>
      48.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Yang
        </surname>
        <given-names>
         TL
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genetic association study of common mitochondrial variants on body fat mass
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2011
      </year>
      <volume>
       6
      </volume>
      <fpage>
       21595
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2011PLoSO...621595Y
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0021595
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR49">
     <label>
      49.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Parker
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Phillips
        </surname>
        <given-names>
         DIW
        </given-names>
       </name>
       <name>
        <surname>
         Cockington
        </surname>
        <given-names>
         RA
        </given-names>
       </name>
       <name>
        <surname>
         Cull
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Poulton
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       A common mitchondrial DNA variant is associated with thinness in mothers and their 20-yr-old offspring
      </article-title>
      <source>
       Am. J. Physiol. Endocrinol. Metab.
      </source>
      <year>
       2005
      </year>
      <volume>
       289
      </volume>
      <fpage>
       E1110
      </fpage>
      <lpage>
       E1114
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD28XlslKqtA%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       15998658
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1152/ajpendo.00600.2004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR50">
     <label>
      50.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Nardelli
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Haplogroup T is an obesity risk factor: mitochondrial DNA haplotyping in a morbid obese population from Southern Italy
      </article-title>
      <source>
       Biomed. Res. Int.
      </source>
      <year>
       2013
      </year>
      <volume>
       2013
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
      <pub-id pub-id-type="doi">
       10.1155/2013/631082
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR51">
     <label>
      51.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goisis
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Remes
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Martikainen
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Klemetti
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Myrskylä
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Medically assisted reproduction and birth outcomes: a within-family analysis using Finnish population registers
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2019
      </year>
      <volume>
       393
      </volume>
      <fpage>
       1225
      </fpage>
      <lpage>
       1232
      </lpage>
      <pub-id pub-id-type="pmid">
       30655015
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(18)31863-4
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR52">
     <label>
      52.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Amaral
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Lourenço
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Marques
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Ramalho-Santos
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondria functionality and sperm quality
      </article-title>
      <source>
       Reproduction
      </source>
      <year>
       2013
      </year>
      <volume>
       146
      </volume>
      <fpage>
       163
      </fpage>
      <lpage>
       174
      </lpage>
      <pub-id pub-id-type="doi">
       10.1530/REP-13-0178
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR53">
     <label>
      53.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ameele
        </surname>
        <given-names>
         JVan
        </given-names>
       </name>
       <name>
        <surname>
         Den
        </surname>
        <given-names>
         Li,AYZ
        </given-names>
       </name>
       <name>
        <surname>
         Ma
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Chinnery
        </surname>
        <given-names>
         PF
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial heteroplasmy beyond the oocyte bottleneck
      </article-title>
      <source>
       Semin. Cell Dev. Biol.
      </source>
      <year>
       2020
      </year>
      <volume>
       97
      </volume>
      <fpage>
       156
      </fpage>
      <lpage>
       166
      </lpage>
      <pub-id pub-id-type="pmid">
       31611080
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.semcdb.2019.10.001
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR54">
     <label>
      54.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cecchino
        </surname>
        <given-names>
         GN
        </given-names>
       </name>
       <name>
        <surname>
         D
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Garcia-velasco
        </surname>
        <given-names>
         JA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA copy number as a predictor of embryo viability
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2019
      </year>
      <volume>
       111
      </volume>
      <fpage>
       205
      </fpage>
      <lpage>
       211
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1MXjtVSisQ%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       30611549
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2018.11.021
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR55">
     <label>
      55.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Dumollard
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Duchen
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Carroll
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The role of mitochondrial function in the oocyte and embryo
      </article-title>
      <source>
       Curr. Top. Dev. Biol.
      </source>
      <year>
       2007
      </year>
      <volume>
       77
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       49
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD2sXmt1Gltb4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       17222699
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0070-2153(06)77002-8
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR56">
     <label>
      56.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gu
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes Ling
      </article-title>
      <source>
       Cell Mol. Life Sci.
      </source>
      <year>
       2015
      </year>
      <volume>
       72
      </volume>
      <fpage>
       251
      </fpage>
      <lpage>
       271
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhs12nt7rN
      </pub-id>
      <pub-id pub-id-type="pmid">
       25280482
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00018-014-1739-4
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR57">
     <label>
      57.
     </label>
     <mixed-citation publication-type="other">
      Otten, A. B. C. &amp; Smeets, H. J. M. Evolutionary defined role of the mitochondrial DNA in fertility, disease and ageing.
      <italic>
       Hum. Reprod. Update
      </italic>
      <bold>
       21
      </bold>
      , 671–689 (2015).
     </mixed-citation>
    </ref>
    <ref id="CR58">
     <label>
      58.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ramalho-Santos
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial functionality in reproduction: from gonads and gametes to embryos and embryonic stem cells
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2009
      </year>
      <volume>
       15
      </volume>
      <fpage>
       553
      </fpage>
      <lpage>
       572
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1MXhtVals7nI
      </pub-id>
      <pub-id pub-id-type="pmid">
       19414527
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dmp016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR59">
     <label>
      59.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Chao
        </surname>
        <given-names>
         H-T
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Repeated ovarian stimulations induce oxidative damage and mitochondrial DNA mutations in mouse ovaries
      </article-title>
      <source>
       Ann. N. Y. Acad. Sci.
      </source>
      <year>
       2005
      </year>
      <volume>
       1042
      </volume>
      <fpage>
       148
      </fpage>
      <lpage>
       156
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2005NYASA1042..148C
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD2MXot1Cqsbs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       15965057
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1196/annals.1338.016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR60">
     <label>
      60.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         TC
        </given-names>
       </name>
       <name>
        <surname>
         Kubisch
        </surname>
        <given-names>
         HM
        </given-names>
       </name>
       <name>
        <surname>
         Brenner
        </surname>
        <given-names>
         CA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA deletions in rhesus macaque oocytes and embryos
      </article-title>
      <source>
       Mol. Hum. Reprod.
      </source>
      <year>
       2005
      </year>
      <volume>
       11
      </volume>
      <fpage>
       785
      </fpage>
      <lpage>
       789
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD28XhtFahtrg%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       16373367
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/molehr/gah227
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR61">
     <label>
      61.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ge
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Impaired mitochondrial function in murine oocytes is associated with controlled ovarian hyperstimulation and in vitro maturation
      </article-title>
      <source>
       Reprod. Fertil. Dev.
      </source>
      <year>
       2012
      </year>
      <volume>
       24
      </volume>
      <fpage>
       945
      </fpage>
      <lpage>
       952
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38Xht1Grs7vK
      </pub-id>
      <pub-id pub-id-type="pmid">
       22935155
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1071/RD11212
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR62">
     <label>
      62.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Schon
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         DiMauro
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Hirano
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Human mitochondrial DNA: roles of inherited and somatic mutations
      </article-title>
      <source>
       Nat. Rev. Genet.
      </source>
      <year>
       2012
      </year>
      <volume>
       13
      </volume>
      <fpage>
       878
      </fpage>
      <lpage>
       890
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38Xhs1OgsLfO
      </pub-id>
      <pub-id pub-id-type="pmid">
       23154810
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3959762
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrg3275
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR63">
     <label>
      63.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kennedy
        </surname>
        <given-names>
         SR
        </given-names>
       </name>
       <name>
        <surname>
         Salk
        </surname>
        <given-names>
         JJ
        </given-names>
       </name>
       <name>
        <surname>
         Schmitt
        </surname>
        <given-names>
         MW
        </given-names>
       </name>
       <name>
        <surname>
         Loeb
        </surname>
        <given-names>
         LA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage
      </article-title>
      <source>
       PLoS Genet
      </source>
      <year>
       2013
      </year>
      <volume>
       9
      </volume>
      <fpage>
       e1003794
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsFKitb3I
      </pub-id>
      <pub-id pub-id-type="pmid">
       24086148
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3784509
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pgen.1003794
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR64">
     <label>
      64.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Naue
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Evidence for frequent and tissue-specific sequence heteroplasmy in human mitochondrial DNA
      </article-title>
      <source>
       Mitochondrion
      </source>
      <year>
       2015
      </year>
      <volume>
       20
      </volume>
      <fpage>
       82
      </fpage>
      <lpage>
       94
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXitFygsbzM
      </pub-id>
      <pub-id pub-id-type="pmid">
       25526677
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.mito.2014.12.002
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR65">
     <label>
      65.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Nekhaeva
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues
      </article-title>
      <source>
       Proc. Natl Acad. Sci. USA
      </source>
      <year>
       2002
      </year>
      <volume>
       99
      </volume>
      <fpage>
       5521
      </fpage>
      <lpage>
       5526
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2002PNAS...99.5521N
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD38XjtFKltrk%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       11943860
      </pub-id>
      <pub-id pub-id-type="pmcid">
       122802
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1073/pnas.072670199
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR66">
     <label>
      66.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sanchez-Contreras
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The multi-tissue landscape of somatic mtDNA mutations indicates tissue-specific accumulation and removal in aging
      </article-title>
      <source>
       Elife
      </source>
      <year>
       2023
      </year>
      <volume>
       12
      </volume>
      <fpage>
       e83395
      </fpage>
      <pub-id pub-id-type="pmid">
       36799304
      </pub-id>
      <pub-id pub-id-type="pmcid">
       10072880
      </pub-id>
      <pub-id pub-id-type="doi">
       10.7554/eLife.83395
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR67">
     <label>
      67.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Herrero-Martin
        </surname>
        <given-names>
         MD
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A MELAS/MERRF phenotype associated with the mitochondrial DNA 5521G&gt;A mutation
      </article-title>
      <source>
       J. Neurol. Neurosurg. Psychiatry
      </source>
      <year>
       2010
      </year>
      <volume>
       81
      </volume>
      <fpage>
       471
      </fpage>
      <lpage>
       472
      </lpage>
      <pub-id pub-id-type="pmid">
       20360171
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1136/jnnp.2009.173831
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR68">
     <label>
      68.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Pathogenic mitochondrial DNA 3243A&gt;G mutation: from genetics to phenotype
      </article-title>
      <source>
       Front. Genet.
      </source>
      <year>
       2022
      </year>
      <volume>
       13
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       14
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2022FrMat...9....1L
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR69">
     <label>
      69.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Fu
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Broadening the phenotype of m.5703G&gt;A mutation in mitochondrial tRNAAsn gene from mitochondrial myopathy to myoclonic epilepsy with ragged red fibers syndrome
      </article-title>
      <source>
       Chin. Med. J.
      </source>
      <year>
       2019
      </year>
      <volume>
       132
      </volume>
      <fpage>
       865
      </fpage>
      <lpage>
       867
      </lpage>
      <pub-id pub-id-type="pmid">
       30897601
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6595846
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/CM9.0000000000000151
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR70">
     <label>
      70.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kleijkers
        </surname>
        <given-names>
         SHM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       IVF culture medium affects post-natal weight in humans during the first 2 years of life
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2014
      </year>
      <volume>
       29
      </volume>
      <fpage>
       661
      </fpage>
      <lpage>
       669
      </lpage>
      <pub-id pub-id-type="pmid">
       24549211
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu025
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR71">
     <label>
      71.
     </label>
     <mixed-citation publication-type="other">
      Pejaver, V. et al. Inferring the molecular and phenotypic impact of amino acid variants with MutPred2.
      <italic>
       Nat. Commun.
      </italic>
      <bold>
       11
      </bold>
      , 5918 (2020).
     </mixed-citation>
    </ref>
    <ref id="CR72">
     <label>
      72.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lott
        </surname>
        <given-names>
         MT
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       mtDNA Variation and Analysis Using Mitomap and Mitomaster
      </article-title>
      <source>
       Curr. Protoc. Bioinforma.
      </source>
      <year>
       2013
      </year>
      <volume>
       44
      </volume>
      <fpage>
       1.23.1
      </fpage>
      <lpage>
       26
      </lpage>
      <pub-id pub-id-type="doi">
       10.1002/0471250953.bi0123s44
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR73">
     <label>
      73.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         McCormick
        </surname>
        <given-names>
         EM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretation
      </article-title>
      <source>
       Hum. Mutat.
      </source>
      <year>
       2020
      </year>
      <volume>
       41
      </volume>
      <fpage>
       2028
      </fpage>
      <lpage>
       2057
      </lpage>
      <pub-id pub-id-type="pmid">
       32906214
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7717623
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/humu.24107
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR74">
     <label>
      74.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gorman
        </surname>
        <given-names>
         GS
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial diseases
      </article-title>
      <source>
       Nat. Rev. Dis. Prim.
      </source>
      <year>
       2016
      </year>
      <volume>
       2
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       23
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR75">
     <label>
      75.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Stewart
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
       <name>
        <surname>
         Chinnery
        </surname>
        <given-names>
         PF
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease
      </article-title>
      <source>
       Nat. Rev. Genet.
      </source>
      <year>
       2015
      </year>
      <volume>
       16
      </volume>
      <fpage>
       530
      </fpage>
      <lpage>
       542
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2MXhtlKnsLnK
      </pub-id>
      <pub-id pub-id-type="pmid">
       26281784
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrg3966
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR76">
     <label>
      76.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gómez-Durán
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups
      </article-title>
      <source>
       Hum. Mol. Genet.
      </source>
      <year>
       2010
      </year>
      <volume>
       19
      </volume>
      <fpage>
       3343
      </fpage>
      <lpage>
       3353
      </lpage>
      <pub-id pub-id-type="pmid">
       20566709
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/hmg/ddq246
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR77">
     <label>
      77.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Montiel-Sosa
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Differences of sperm motility in mitochondrial DNA haplogroup U sublineages
      </article-title>
      <source>
       Gene
      </source>
      <year>
       2006
      </year>
      <volume>
       368
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       27
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD28XhslKhs7c%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       16326035
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.gene.2005.09.015
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR78">
     <label>
      78.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Payne
        </surname>
        <given-names>
         BaI
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Universal heteroplasmy of human mitochondrial DNA
      </article-title>
      <source>
       Hum. Mol. Genet.
      </source>
      <year>
       2013
      </year>
      <volume>
       22
      </volume>
      <fpage>
       384
      </fpage>
      <lpage>
       390
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38XhvV2gtr%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       23077218
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/hmg/dds435
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR79">
     <label>
      79.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Hahn
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Zuryn
        </surname>
        <given-names>
         S
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The cellular mitochondrial genome landscape in disease
      </article-title>
      <source>
       Trends Cell Biol.
      </source>
      <year>
       2018
      </year>
      <volume>
       xx
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       14
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR80">
     <label>
      80.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Keogh
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Chinnery
        </surname>
        <given-names>
         PF
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Hereditary mtDNA heteroplasmy: a baseline for aging?
      </article-title>
      <source>
       Cell Metab.
      </source>
      <year>
       2013
      </year>
      <volume>
       18
      </volume>
      <fpage>
       463
      </fpage>
      <lpage>
       464
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsFGnsLjP
      </pub-id>
      <pub-id pub-id-type="pmid">
       24093673
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cmet.2013.09.015
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR81">
     <label>
      81.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ross
        </surname>
        <given-names>
         JJM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Germline mitochondrial DNA mutations aggravate ageing and can impair brain development
      </article-title>
      <source>
       Nature
      </source>
      <year>
       2013
      </year>
      <volume>
       501
      </volume>
      <fpage>
       412
      </fpage>
      <lpage>
       415
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2013Natur.501..412R
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhtlCgtL3L
      </pub-id>
      <pub-id pub-id-type="pmid">
       23965628
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3820420
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nature12474
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR82">
     <label>
      82.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ross
        </surname>
        <given-names>
         JM
        </given-names>
       </name>
       <name>
        <surname>
         Coppotelli
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Hoffer
        </surname>
        <given-names>
         BJ
        </given-names>
       </name>
       <name>
        <surname>
         Olson
        </surname>
        <given-names>
         L
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Maternally transmitted mitochondrial DNA mutations can reduce lifespan
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2014
      </year>
      <volume>
       4
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014NatSR...4E6569R
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2MXksVyru78%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       25299268
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4190956
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/srep06569
      </pub-id>
      <elocation-id>
       6569
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR83">
     <label>
      83.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Picca
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The contribution of mitochondrial DNA alterations to aging, cancer, and neurodegeneration
      </article-title>
      <source>
       Exp. Gerontol.
      </source>
      <year>
       2023
      </year>
      <volume>
       178
      </volume>
      <fpage>
       112203
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3sXhtVOhsLnE
      </pub-id>
      <pub-id pub-id-type="pmid">
       37172915
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.exger.2023.112203
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR84">
     <label>
      84.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kang
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Age-related accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs
      </article-title>
      <source>
       Cell Stem Cell
      </source>
      <year>
       2016
      </year>
      <volume>
       18
      </volume>
      <fpage>
       625
      </fpage>
      <lpage>
       636
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XmtFCitL0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27151456
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.stem.2016.02.005
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR85">
     <label>
      85.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Rebolledo-Jaramillo
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA
      </article-title>
      <source>
       Proc. Natl Acad. Sci. USA
      </source>
      <year>
       2014
      </year>
      <volume>
       111
      </volume>
      <fpage>
       15474
      </fpage>
      <lpage>
       15479
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014PNAS..11115474R
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhslKmtbzJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       25313049
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4217420
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1073/pnas.1409328111
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR86">
     <label>
      86.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zaidi
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Bottleneck and selection in the germline and maternal age influence transmission of mitochondrial DNA in human pedigrees
      </article-title>
      <source>
       Proc. Natl Acad. Sci. USA
      </source>
      <year>
       2019
      </year>
      <volume>
       116
      </volume>
      <fpage>
       25172
      </fpage>
      <lpage>
       25178
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2019PNAS..11625172Z
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1MXitl2hurjJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       31757848
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6911200
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1073/pnas.1906331116
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR87">
     <label>
      87.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Arbeithuber
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Age-related accumulation of de novo mitochondrial mutations in mammalian oocytes and somatic tissues
      </article-title>
      <source>
       PLoS Biol.
      </source>
      <year>
       2020
      </year>
      <volume>
       18
      </volume>
      <fpage>
       e3000745
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXhsVeqtL3L
      </pub-id>
      <pub-id pub-id-type="pmid">
       32667908
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7363077
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pbio.3000745
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR88">
     <label>
      88.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Burgstaller
        </surname>
        <given-names>
         JP
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Large-scale genetic analysis reveals mammalian mtDNA heteroplasmy dynamics and variance increase through lifetimes and generations
      </article-title>
      <source>
       Nat. Commun.
      </source>
      <year>
       2018
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       12
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXht1CgurnI
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41467-018-04797-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR89">
     <label>
      89.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kiserud
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The World Health Organization fetal growth charts: concept, findings, interpretation, and application
      </article-title>
      <source>
       Am. J. Obstet. Gynecol.
      </source>
      <year>
       2018
      </year>
      <volume>
       218
      </volume>
      <fpage>
       S619
      </fpage>
      <lpage>
       S629
      </lpage>
      <pub-id pub-id-type="pmid">
       29422204
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.ajog.2017.12.010
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR90">
     <label>
      90.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Schimmel
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The effects of maternal age and parity on maternal and neonatal outcome
      </article-title>
      <source>
       Arch. Gynecol. Obstet.
      </source>
      <year>
       2015
      </year>
      <volume>
       291
      </volume>
      <fpage>
       793
      </fpage>
      <lpage>
       798
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhsFyit77I
      </pub-id>
      <pub-id pub-id-type="pmid">
       25227657
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00404-014-3469-0
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR91">
     <label>
      91.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wang
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Changing trends of birth weight with maternal age: a cross-sectional study in Xi’an city of Northwestern China
      </article-title>
      <source>
       BMC Pregnancy Childbirth
      </source>
      <year>
       2020
      </year>
      <volume>
       20
      </volume>
      <pub-id pub-id-type="pmid">
       33256654
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7708914
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12884-020-03445-2
      </pub-id>
      <elocation-id>
       744
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR92">
     <label>
      92.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Floros
        </surname>
        <given-names>
         VI
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Segregation of mitochondrial DNA heteroplasmy through a developmental genetic bottleneck in human embryos
      </article-title>
      <source>
       Nat. Cell Biol.
      </source>
      <year>
       2018
      </year>
      <volume>
       20
      </volume>
      <fpage>
       144
      </fpage>
      <lpage>
       151
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXkslGis78%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       29335530
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6551220
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41556-017-0017-8
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR93">
     <label>
      93.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wei
        </surname>
        <given-names>
         W
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Germline selection shapes human mitochondrial DNA diversity
      </article-title>
      <source>
       Science
      </source>
      <year>
       2019
      </year>
      <volume>
       364
      </volume>
      <fpage>
       eaau6520
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1MXhtVKgtr7N
      </pub-id>
      <pub-id pub-id-type="pmid">
       31123110
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1126/science.aau6520
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR94">
     <label>
      94.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mak
        </surname>
        <given-names>
         W
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       789
      </fpage>
      <lpage>
       794
      </lpage>
      <pub-id pub-id-type="pmid">
       26908846
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4791919
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew024
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR95">
     <label>
      95.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunkara
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         LaMarca
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Polyzos
        </surname>
        <given-names>
         NP
        </given-names>
       </name>
       <name>
        <surname>
         Seed
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         Khalaf
        </surname>
        <given-names>
         Y
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of a nationwide data
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2261
      </fpage>
      <lpage>
       2267
      </lpage>
      <pub-id pub-id-type="pmid">
       27591229
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew184
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR96">
     <label>
      96.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunkara
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         La Marca
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Seed
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         Khalaf
        </surname>
        <given-names>
         Y
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2015
      </year>
      <volume>
       30
      </volume>
      <fpage>
       1473
      </fpage>
      <lpage>
       1480
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhsF2nt77N
      </pub-id>
      <pub-id pub-id-type="pmid">
       25883033
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dev076
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR97">
     <label>
      97.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Magnusson
        </surname>
        <given-names>
         Å
        </given-names>
       </name>
       <name>
        <surname>
         Källen
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Thurin-Kjellberg
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Bergh
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The number of oocytes retrieved during IVF: a balance between efficacy and safety
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2018
      </year>
      <volume>
       33
      </volume>
      <fpage>
       58
      </fpage>
      <lpage>
       64
      </lpage>
      <pub-id pub-id-type="pmid">
       29136154
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dex334
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR98">
     <label>
      98.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Nelissen
        </surname>
        <given-names>
         EC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Further evidence that culture media affect perinatal outcome: findings after transfer of fresh and cryopreserved embryos
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2012
      </year>
      <volume>
       27
      </volume>
      <fpage>
       1966
      </fpage>
      <lpage>
       1976
      </lpage>
      <pub-id pub-id-type="pmid">
       22552689
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/des145
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR99">
     <label>
      99.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wen
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2012
      </year>
      <volume>
       97
      </volume>
      <fpage>
       1331
      </fpage>
      <lpage>
       1337.e4
      </lpage>
      <pub-id pub-id-type="pmid">
       22480819
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2012.02.053
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR100">
     <label>
      100.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Danan
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Evaluation of parental mitochondrial inheritance in neonates born after intracytoplasmic sperm injection
      </article-title>
      <source>
       Am. J. Hum. Genet.
      </source>
      <year>
       1999
      </year>
      <volume>
       65
      </volume>
      <fpage>
       463
      </fpage>
      <lpage>
       473
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DyaK1MXlsFSgsrY%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10417289
      </pub-id>
      <pub-id pub-id-type="pmcid">
       1377945
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1086/302484
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR101">
     <label>
      101.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Belva
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Semen quality of young adult ICSI offspring: the first results
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2811
      </fpage>
      <lpage>
       2820
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BC2svmvVyltA%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27707840
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew245
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR102">
     <label>
      102.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Belva
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Reproductive hormones of ICSI-conceived young adult men: the first results
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2017
      </year>
      <volume>
       32
      </volume>
      <fpage>
       439
      </fpage>
      <lpage>
       446
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXitFCku77J
      </pub-id>
      <pub-id pub-id-type="pmid">
       28007789
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew324
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR103">
     <label>
      103.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Spits
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Whole-genome multiple displacement amplification from single cells
      </article-title>
      <source>
       Nat. Protoc.
      </source>
      <year>
       2006
      </year>
      <volume>
       1
      </volume>
      <fpage>
       1965
      </fpage>
      <lpage>
       1970
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD2sXhtFagtrvM
      </pub-id>
      <pub-id pub-id-type="pmid">
       17487184
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nprot.2006.326
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR104">
     <label>
      104.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mertens
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Detection of heteroplasmic variants in the mitochondrial genome through massive parallel sequencing
      </article-title>
      <source>
       Bio-Protoc.
      </source>
      <year>
       2019
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       19
      </lpage>
      <pub-id pub-id-type="doi">
       10.21769/BioProtoc.3283
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR105">
     <label>
      105.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zambelli
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Accurate and comprehensive analysis of single nucleotide variants and large deletions of the human mitochondrial genome in DNA and single cells
      </article-title>
      <source>
       Eur. J. Hum. Genet.
      </source>
      <year>
       2017
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1229
      </fpage>
      <lpage>
       1236
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhtlyjtb%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       28832570
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5643964
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/ejhg.2017.129
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR106">
     <label>
      106.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Weissensteiner
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       mtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloud
      </article-title>
      <source>
       Nucleic Acids Res.
      </source>
      <year>
       2016
      </year>
      <volume>
       44
      </volume>
      <fpage>
       gkw247
      </fpage>
      <pub-id pub-id-type="doi">
       10.1093/nar/gkw247
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR107">
     <label>
      107.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cibulskis
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
      </article-title>
      <source>
       Nat. Biotechnol.
      </source>
      <year>
       2013
      </year>
      <volume>
       31
      </volume>
      <fpage>
       213
      </fpage>
      <lpage>
       219
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXjsFCntbc%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23396013
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3833702
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nbt.2514
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR108">
     <label>
      108.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Castellana
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Rónai
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Mazza
        </surname>
        <given-names>
         T
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       MitImpact: an exhaustive collection of pre-computed pathogenicity predictions of human mitochondrial non-synonymous variants
      </article-title>
      <source>
       Hum. Mutat.
      </source>
      <year>
       2015
      </year>
      <volume>
       36
      </volume>
      <fpage>
       E2413
      </fpage>
      <lpage>
       E2422
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2MXit12lt7g%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       25516408
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/humu.22720
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR109">
     <label>
      109.
     </label>
     <mixed-citation publication-type="other">
      Sonney, S. et al. Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP.
      <italic>
       PLoS Comput. Biol.
      </italic>
      <bold>
       13
      </bold>
      , e1005867 (2017).
     </mixed-citation>
    </ref>
    <ref id="CR110">
     <label>
      110.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mertens
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA variants segregate during human preimplantation development into genetically different cell lineages that are maintained postnatally
      </article-title>
      <source>
       Hum. Mol. Genet.
      </source>
      <year>
       2022
      </year>
      <volume>
       31
      </volume>
      <fpage>
       3629
      </fpage>
      <lpage>
       3642
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3sXptFaksLY%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       35285472
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9616571
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/hmg/ddac059
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR111">
     <label>
      111.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zambelli
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Random mutagenesis, clonal events and embryonic or somatic origin determine the mitochondrial DNA variant type and load in human pluripotent stem cells
      </article-title>
      <source>
       Stem Cell Rep.
      </source>
      <year>
       2018
      </year>
      <volume>
       11
      </volume>
      <fpage>
       102
      </fpage>
      <lpage>
       114
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhtF2mu7rE
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.stemcr.2018.05.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR112">
     <label>
      112.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Spelbrink
        </surname>
        <given-names>
         JN
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges
      </article-title>
      <source>
       IUBMB Life
      </source>
      <year>
       2010
      </year>
      <volume>
       62
      </volume>
      <fpage>
       19
      </fpage>
      <lpage>
       32
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3cXktlemtw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       20014006
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/iub.282
      </pub-id>
     </mixed-citation>
    </ref>
   </ref-list>
  </ref-list>
  <app-group>
   <app id="App1" specific-use="web-only">
    <sec id="Sec14">
     <title>
      Taarifa za ziada
     </title>
     <p id="Par36">
      <supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM1_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Supplementary Information
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM2_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Peer Review File
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM3_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Description of Additional Supplementary Files
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM4" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM4_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 1
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM5" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM5_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 2
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM6" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM6_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 3
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM7" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM7_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 4
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM8" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM8_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 5
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM9" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM9_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 6
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM10" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM10_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Reporting Summary
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
    <sec id="Sec15">
     <title>
      Data ya chanzo
     </title>
     <p id="Par37">
      <supplementary-material content-type="local-data" id="MOESM11" xlink:title="Source data">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM11_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Source Data
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
   </app>
  </app-group>
  <notes notes-type="ESMHint">
   <title>
    Taarifa za ziada
   </title>
   <p>
    The online version contains supplementary material available at
    <ext-link ext-link-type="doi" xlink:href="10.1038/s41467-024-45446-1">
     https://doi.org/10.1038/s41467-024-45446-1
    </ext-link>
    .
   </p>
  </notes>
  <notes notes-type="Misc">
   <p>
    <bold>
     Publisher’s note
    </bold>
    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
   </p>
  </notes>
 </back>
</article>
